Patent Application
20130217829
All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
The present invention pertains to semi- and fully interpenetrating polymer networks, methods of making semi- and fully interpenetrating polymer networks, articles made from such semi- and fully interpenetrating polymer networks, and methods of using such articles.
Fully interpenetrating polymer networks (IPN's) and semi-interpenetrating polymer networks (“semi-IPN's”) have been created from a variety of starting materials and have been used for a variety of applications. IPN's and semi-IPN's can combine the beneficial properties of the polymers from which they are made and can avoid some of the undesirable properties of their component polymers.
Prior IPN's and semi-IPN's have been proposed for use in biomedical applications, such as a coating for an implant or as artificial cartilage. See, e.g., U.S. Patent Publ. No. 2005/0147685; U.S. Patent Publ. No. 2009/0035344; and U.S. Patent Publ. No. 2009/008846. The utility of prior IPN's and semi-IPN's for their proposed applications is limited by the properties of those compositions, however. In addition, the starting materials and processes of making such prior compositions limit not only the resulting properties of the IPN or semi-IPN but also the commercial viability of the manufacturing processes and the articles made in such processes. Also, the mechanical properties of prior IPNs and semi-IPNs are often limited by the mechanical properties of the component polymers used, which in the case of most intrinsically hydrophilic, water-swellable polymers, are usually quite low. For example, the prior art has not described a viable process for making a water-swellable IPN or semi-IPN from commercially available hydrophobic thermoset or thermoplastic polymers, such as polyurethane or ABS.
Finally, the utility of prior IPN and semi-IPN compositions and the value of the articles formed from such compositions have been limited by the inability to create IPN's and semi-IPN's with desired characteristics, such as strength, lubricity and wear-resistance.
The mechanical properties desired for certain medical applications is often outside the range of possibility of many hydrophilic starting materials. Hence, one aspect of this invention takes advantage of the high mechanical strength of hydrophobic starting materials and combines those materials with certain ionic polymers as a useful way to achieve the goal of high mechanical strength in addition to other desirable properties. Thus, while the prior art took water-swellable polymers and tried to make them stronger, one aspect of this invention takes strong materials and makes them more water-swellable. A second aspect of this invention is to take materials and make them more adhesive to materials to which they are otherwise not adhesive. Examples of two such materials are polyurethanes and PMMA bone cement. PMMA bone cement is known as a “grouting” compound that acts as an anchoring material for orthopaedic implants to bone by way of mutual mechanical interlocking. One aspect of the invention describes a way of introducing a constituent of bone cement into polyurethane in order to facilitate a direct bond with bone cement rather than just mechanical interlocking. In some embodiments, this bonding eliminates the need for a mechanical interface between a relatively compliant device and bone cement, and causes them to bear loads and transfer loads as a single body rather than as two bodies.
For purposes of this application, an “interpenetrating polymer network” or “IPN” is a material comprising two or more polymer networks which are at least partially interlaced on a molecular scale, but not covalently bonded to each other, and cannot be separated unless chemical bonds are broken. A “semi-interpenetrating polymer network” or “semi-IPN” is a material comprising one or more polymer networks and one or more linear or branched polymers characterized by the penetration on a molecular scale of at least one of the networks by at least some of the linear or branched macromolecules. As distinguished from an IPN, a semi-IPN is a polymer blend in which at least one of the component polymer networks is not chemically crosslinked by covalent bonds.
A “polymer” is a substance comprising macromolecules, including homopolymers (a polymer derived from one species of monomer) and copolymers (a polymer derived from more than one species of monomer). A “hydrophobic polymer” is a pre-formed polymer network having at least one of the following two properties: (1) a surface water contact angle of at least 45° and (2) exhibits water absorption of 2.5% or less after 24 hours at room temperature according to ASTM test standard D570. A “hydrophilic polymer” is a polymer network having a surface water contact angle less than 45° and exhibits water absorption of more than 2.5% after 24 hours at room temperature according to ASTM test standard D570. An “ionic polymer” is defined as a polymer comprised of macromolecules containing at least 2% by weight ionic or ionizable monomers (or both), irrespective of their nature and location. An “ionizable monomer” is a small molecule that can be chemically bonded to other monomers to form a polymer and which also has the ability to become negatively charged due the presence of acid functional groups such carboxylic acid and/or sulfonic acid. A “thermoset polymer” is one that doesn't melt when heated, unlike a thermoplastic polymer. Thermoset polymers “set” into a given shape when first made and afterwards do not flow or melt, but rather decompose upon heating and are often highly crosslinked and/or covalently crosslinked. A “thermoplastic polymer” is one which melts or flows when heated, unlike thermoset polymers. Thermoplastic polymers are usually not covalently crosslinked. “Phase separation” is defined as the conversion of a single-phase system into a multi-phase system; especially the separation of two immiscible blocks of a block co-polymer into two phases, with the possibility of a small interphase in which a small degree of mixing occurs.
The present invention includes a process for modifying common commercially available hydrophobic thermoset or thermoplastic polymers, such as polyurethane or ABS to provide new properties, such as strength, lubricity, electrical conductivity and wear-resistance. Other possible hydrophobic thermoset or thermoplastic polymers are described below. The invention also includes the IPN and semi-IPN compositions as well as articles made from such compositions and methods of using such articles. The IPN and semi-IPN compositions of this invention may attain one or more of the following characteristics: High tensile and compressive strength; low coefficient of friction; high water content and swellability; high permeability; biocompatibility; and biostability.
Applications of the invention are the creation of hydrophilic, lubricious sidings or coatings to reduce the static and dynamic coefficient of friction between two bearing surfaces and to reduce drag and/or biofilm formation and/or barnacle formation in marine vessels, diving or swimming suits, other water crafts or water-borne objects, or pipes. Furthermore, the invention has potential in electrochemical applications that require conduction of electrical current, or permeability of ions such as proton exchange membranes, fuel cells, filtration devices, and ion-exchange membranes. In addition, the invention can be used as a method for making bearings and moving parts for applications such as engines, pistons, or other machines or machine parts. The invention can also be used in numerous biomedical applications including cartilage substitutes, orthopaedic joint replacement and resurfacing devices or components thereof, intervertebral discs, stents, vascular or urinary catheters, condoms, heart valves, vascular grafts, and both short-term and long-term implants in other areas of the body, such as skin, brain, spine, the gastro-intestinal system, the larynx, and soft tissues in general. In addition, it can be used as a component of various surgical tools and instruments. In all of these applications drugs can be incorporated into the material for localized drug delivery. These interpenetrating polymer networks can also be used to fabricate specific drug delivery vehicles in which a therapeutic agent is released from the polymer matrix. One aspect of the invention provides compositions of a water-swellable IPN or semi-IPN of a hydrophobic thermoset or thermoplastic polymer and an ionic polymer. In some embodiments, the IPN or semi-IPN exhibits a lower coefficient of friction than the hydrophobic thermoset or thermoplastic polymer. In some embodiments, the IPN or semi-IPN is more water-swellable, exhibits higher resistance to creep, and/or exhibits a higher conductivity and permeability than the hydrophobic thermoset or thermoplastic polymer. Some embodiments of the composition also include an anti-oxidation agent.
In some embodiments, the IPN or semi-IPN is formed by diffusing an ionizable monomer precursor solution into the hydrophobic thermoset or thermoplastic polymer and polymerizing the monomers to form the ionic polymer.
In some embodiments, the composition also includes water, which may form a hydration gradient from a first portion of the composition to a second portion of the composition. An electrolyte may be dissolved in the water. The IPN or semi-IPN may also be negatively charged. In various embodiments, the hydrophobic thermoset or thermoplastic polymer may be physically entangled or chemically crosslinked with the ionic polymer.
In some embodiments, the hydrophobic thermoset or thermoplastic polymer has ordered and disordered domains, and the ionic polymer may be disposed in the disordered domains.
In various embodiments the hydrophobic thermoset or thermoplastic polymer may be selected from the group consisting of polyurethane, polymethyl methacrylate, polydimethylsiloxane, and acrylonitrile butadiene styrene. The ionic polymer may be, e.g., a poly(acrylic acid) or poly(sulfopropyl methacrylate), combinations, or derivatives thereof. The ionic polymer may include carboxylate groups and/or sulfonate groups.
In some embodiments, the ionic polymer forms a concentration gradient from a first portion of the composition to a second portion of the composition. The concentration gradient may, e.g., provide a stiffness and/or hydration gradient within the composition.
Some embodiments include a second hydrophobic thermoset or thermoplastic polymer which may be disposed in a layer separate from the first hydrophobic thermoset or thermoplastic polymer or may be diffused throughout the first hydrophobic thermoset or thermoplastic polymer.
Another aspect of the invention provides a process for producing a water-swellable IPN or semi-IPN from an hydrophobic thermoset or thermoplastic polymer including the following steps: placing an ionizable monomer solution in contact with a solid form of the hydrophobic thermoset or thermoplastic polymer; diffusing the ionizable monomer solution into the thermoset or thermoplastic polymer; and polymerizing the ionizable monomers to form a ionic polymer inside the thermoset or thermoplastic polymer, thereby forming the IPN or semi-IPN.
Some embodiments include the step of adding an anti-oxidation agent. Some embodiments include the step of swelling the IPN or semi-IPN with water, e.g., to form a hydration gradient from a first portion of the composition to a second portion of the composition. The method may also include the step of swelling the IPN or semi-IPN with an electrolyte solution. Various embodiments include the steps of chemically crosslinking or physically entangling the hydrophobic thermoset or thermoplastic polymer with the ionic polymer.
In embodiments in which the hydrophobic thermoset or thermoplastic polymer has ordered and disordered domains, the method may include the step of swelling the disordered domains with the ionizable monomer solution prior to the polymerizing step.
In some embodiments, the hydrophobic thermoset or thermoplastic polymer is selected from the group consisting of polyurethane, polymethyl methacrylate, polydimethylsiloxane, and acrylonitrile butadiene styrene. The ionizable monomer solution may be an acrylic acid solution and may comprise monomers with carboxylate groups and/or sulfonate groups.
In some embodiments, the method includes the step of forming a concentration gradient of the ionic polymer within the IPN or semi-IPN through regioselective diffusion of the ionizable monomer solution through the hydrophobic thermoset of thermoplastic polymer to, e.g., provide a stiffness and/or hydration gradient within the composition.
Some embodiments of the method may include, prior to the polymerizing step, the steps of placing the ionizable monomer solution in contact with a solid form of a second hydrophobic thermoset or thermoplastic polymer; and diffusing the ionizable monomer solution into the second hydrophobic thermoset or thermoplastic polymer. In such embodiments, the second hydrophobic thermoset or thermoplastic polymer may be in a separate layer adjacent to the first hydrophobic thermoset or thermoplastic polymer or may be diffused within the first hydrophobic thermoset or thermoplastic polymer.
Some embodiments include the step of changing the IPN or semi-IPN from a first shape to a second shape, such as by heating the IPN or semi-IPN.
Yet another aspect of the invention provides a medical implant including a water-swellable IPN or semi-IPN including an hydrophobic thermoset or thermoplastic polymer and an ionic polymer, the implant having a bone contact surface shaped to conform to a bone surface. Some embodiments also include a fluid capsule disposed in an interior region of the implant. Some embodiments have an insertion portion adapted to be inserted into a bone and a joint interface portion adapted to be disposed within a joint space, such as bone screws, sutures, or staples engaged with the IPN or semi-IPN and adapted to engage the bone to attach the IPN or semi-IPN to the bone and/or a stem extending from the bone contact surface and adapted to be inserted into the bone. The medical implant may also be incorporated as a bearing component of another device, such as a metal-based prosthesis.
The medical implant may also include a bonding agent adapted to attach the medical implant to a bone, such as a bone ingrowth surface formed on the bone contact surface. In some embodiments, the ionic polymer forms a concentration gradient from a first portion of the implant to a second portion of the implant. Some embodiments have a second hydrophobic thermoset or thermoplastic polymer adjacent to the first hydrophobic thermoset or thermoplastic polymer, the ionic polymer interpenetrating at least the first hydrophobic thermoset or thermoplastic polymer.
In some embodiments, the water-swellable IPN or semi-IPN has properties mimicking stiffness and lubricity properties of natural cartilage and may be adapted and configured to replace cartilage in a joint. The IPN or semi-IPN may have a shape selected from the group consisting of a cap, a cup, a plug, a mushroom, a stem, and a patch, and it may be adapted to fit a condyle, tibial plateau, meniscus, labrum, or glenoid.
Still another aspect of the invention provides a method of repairing an orthopedic joint including the steps of replacing natural cartilage with a water-swellable IPN or semi-IPN having a hydrophobic thermoset or thermoplastic polymer and an ionic polymer and engaging the IPN or semi-IPN with a bone surface defining the joint. The method may also include the steps of bonding, suturing, stapling, and/or screwing the IPN or semi-IPN to the bone surface. The method may also include incorporating the material as a bearing component of another device, such as a metal-based prosthesis. The method may also include the step of inserting a stem portion into the bone surface. The orthopedic joint may be selected from a group consisting of a shoulder joint, a finger joint, a hand joint, an ankle joint, a foot joint, a toe joint, a knee medial compartment joint, a patellofemoral joint, a total knee joint, a knee meniscus, a femoral joint, an acetabular joint, a labral joint, an elbow, an intervertebral facet, and a vertebral joint.
Yet another aspect of the invention provides a marine hull coating including a water-swellable IPN or semi-IPN including a hydrophobic thermoset or thermoplastic polymer and an ionic polymer, the coating having a hull contact surface adapted to attach to a marine hull. The coating may also include an ultraviolet light protection agent and/or an anti-oxidation agent.
Some embodiments of the invention include compositions of matter having an IPN or semi-IPN that includes a hydrophobic thermoset or thermoplastic polymer and a non-ionic polymer where the IPN or semi-IPN is capable of adhering to a material comprising the same non-ionic polymer. Optionally, in any of the preceding embodiments, the non-ionic polymer can be derived from an ethylenically unsaturated monomer such as an acrylic monomer or methacrylic monomer. Optionally, in any of the preceding embodiments, the ethylenically unsaturated monomer does not have an ionizable functional group. Optionally, in any of the preceding embodiments, the non-ionic polymer may be a constituent, component, or ingredient of an interlocking, filler, grouting material or anchoring compound for orthopaedic implants such as bone cement.
Optionally, in any of the preceding embodiments, in further variations, the non-ionic polymer is selected from the group consisting of polymethyl methacrylate and polystyrene. In some embodiments, the hydrophobic thermoset or thermoplastic polymer is a polyurethane polymer.
Optionally, in any of the preceding embodiments, the IPN or semi-IPN exhibits greater adhesiveness, stiffness, shear strength than the hydrophobic thermoset or thermoplastic polymer.
Optionally, in any of the preceding embodiments, the composition can further comprise an anti-oxidation agent.
Optionally, in any of the preceding embodiments, the IPN or semi-IPN is formed by diffusing a non-ionizable monomer precursor into the hydrophobic thermoset or thermoplastic polymer and polymerizing the monomer to form the non-ionic polymer within the hydrophobic thermoset or thermoplastic polymer. Optionally, in any of the preceding embodiments, in some variations, the hydrophobic thermoset or thermoplastic polymer is physically entangled with the non-ionic polymer. In other embodiments, the hydrophobic thermoset or thermoplastic polymer is chemically crosslinked to the non-ionic polymer.
Optionally, in any of the preceding embodiments, the non-ionic polymer forms a concentration gradient from a first portion of the composition to a second portion of the composition. The concentration gradient can provide a modulus, strength, or adhesiveness gradient within the composition.
Another embodiment provides for a composition of matter comprising an IPN or semi-IPN and a bone cement, the IPN or semi-IPN comprising a hydrophobic thermoset or thermoplastic polymer and a non-ionic polymer, and the bone cement comprising the same non-ionic polymer. Optionally, in any of the preceding embodiments, in some embodiments, the IPN exhibits greater adhesiveness with the bone cement than the hydrophobic thermoset or thermoplastic polymer with the bone cement. Optionally, in any of the preceding embodiments, in further embodiments, the non-ionic polymer forms a concentration gradient from a first portion of the composition to a second portion of the composition. In other variations, the concentration gradient provides an adhesiveness gradient within the composition.
Another aspect of the invention provides a process for preparing an IPN or semi-IPN from a hydrophobic thermoset or thermoplastic polymer including the following steps: placing a non-ionizable monomer or a solution of non-ionizable monomer in contact with a solid form of the hydrophobic thermoset or thermoplastic polymer; diffusing the non-ionizable monomer solution into the thermoset or thermoplastic polymer; and polymerizing the non-ionizable monomers to form a non-ionic polymer inside the thermoset or thermoplastic polymer, thereby forming the IPN or semi-IPN. Optionally, in any of the preceding embodiments, the process can also include forming the solid form as a medical implant having a bone interfacing surface and a joint interfacing surface.
In further embodiments, the invention provides for a medical implant comprising a bone interfacing surface, a joint interfacing surface, and an IPN or semi-IPN comprising a hydrophobic thermoset or thermoplastic polymer and a non-ionic polymer, wherein the IPN or semi-IPN is capable of adhering to a material comprising the same non-ionic polymer. Optionally, in any of the preceding embodiments, the IPN is disposed on at least one portion of the bone interfacing surface. Optionally, in any of the preceding embodiments, the non-ionic polymer forms a concentration gradient from a first portion of the medical implant to a second portion of the medical implant. Various embodiments include a medical implant where the concentration gradient provides an adhesiveness, modulus, stiffness, or strength gradient within the medical implant. In other embodiments, the bone interfacing surface and the joint interfacing surface of the implant are configured for a hip joint.
Optionally, in any of the preceding embodiments, the non-ionic polymer in the implant is derived from an ethylenically unsaturated monomer without an ionizable functional group. For example, in some embodiments, the non-ionic polymer is polymethylmethacrylate.
Another aspect of the invention provides for a medical implant comprising a bone interfacing surface, a joint interfacing surface, and an IPN or semi-IPN comprising a hydrophobic thermoset or thermoplastic polymer and an non-ionic polymer, wherein the IPN or semi-IPN is disposed on at least one section of the medical implant and the said section exhibits greater adhesion with a bone cement than the hydrophobic thermoset or thermoplastic polymer.
Various other embodiments include a composition of matter comprising a first IPN or semi-IPN comprising a non-ionic polymer P and a hydrophobic thermoset or thermoplastic polymer T and a second IPN or semi-IPN comprising the same said hydrophobic thermoset or thermoplastic polymer T and a hydrophilic interpenetrating polymer S. Optionally, in any of the preceding embodiments, P can be derived from a non-ionizable, ethylenically unsaturated monomer. Optionally, in any of the preceding embodiments, the ethylenically unsaturated monomer does not have an ionizable functional group. Optionally, in any of the preceding embodiments, T is a polyurethane containing polymer. Optionally, in any of the preceding embodiments, S is an ionic polymer. Optionally, in any of the preceding embodiments, P is polymethylmethacrylate and T is polyurethane.
Optionally, in any of the preceding embodiments, the non-ionic polymer P forms a concentration gradient from a first portion of the composition to a second portion of the composition. Optionally, in any of the preceding embodiments, the non-ionic polymer P forms a concentration gradient from a first portion of the first IPN or semi-IPN to a second portion of the first IPN or semi-IPN. Optionally, in any of the preceding embodiments, the hydrophilic interpenetrating polymer S forms a concentration gradient from a first portion of the composition to a second portion of the composition.
Optionally, in any of the preceding embodiments, the hydrophilic interpenetrating polymer S forms a concentration gradient from a first portion of the second IPN or semi-IPN to a second portion of the second IPN or semi-IPN. Optionally, in any of the preceding embodiments, the composition include at least two concentration gradients, wherein the non-ionic polymer P forms a first concentration gradient from a first portion of the composition to a second portion of composition and the hydrophilic interpenetrating polymer S forms a second concentration gradient from a third portion of the composition to a fourth portion of the composition.
Optionally, in any of the preceding embodiments, the first concentration gradient provides an adhesiveness, lubricious, shear strength, or stiffness gradient within the composition. Optionally, in any of the preceding embodiments, the first concentration gradient provides an adhesiveness gradient and the second concentration gradient provides a lubricious gradient. Optionally, in any of the preceding embodiments, the first concentration gradient and the second concentration gradient partially or fully overlap.
Optionally, in any of the preceding embodiments, the composition further comprises a region of the hydrophobic thermoset or thermoplastic polymer T that is disposed adjacent to an IPN or semi-IPN, wherein the region of the hydrophobic thermoset or thermoplastic polymer T does not contain a polymer P or S.
Yet another aspect of this invention provides for a composition of matter comprising a first IPN or semi-IPN comprising a hydrophobic thermoset or thermoplastic polymer and a non-ionic polymer and a second IPN or semi-IPN comprising the same said hydrophobic thermoset or thermoplastic polymer and a hydrophilic interpenetrating polymer. Optionally, in any of the preceding embodiments, the first IPN or semi-IPN is disposed in a first section of the said hydrophobic thermoset or thermoplastic polymer and the second IPN or semi-IPN is disposed in a second section of the said hydrophobic thermoset or thermoplastic polymer.
Another aspect of this invention provides for a composition of matter comprising at least two IPNs or semi-IPNs, wherein a first IPN or semi-IPN comprises a hydrophobic thermoset or thermoplastic polymer and a non-ionic polymer and a second IPN or semi-IPN comprises a hydrophobic thermoset or thermoplastic polymer and a hydrophilic interpenetrating polymer.
A further embodiment provides for a process for preparing a composition of matter comprising at least two IPNs or semi-IPNs from a hydrophobic thermoset or thermoplastic polymer including steps: placing a first section of a solid form of the hydrophobic thermoset or thermoplastic polymer in contact with a first non-ionizable or ionizable monomer solution; diffusing the first non-ionizable or ionizable monomer solution into the thermoset or thermoplastic polymer; placing a second section of the solid form in contact with a second non-ionizable or ionizable monomer solution; diffusing the second non-ionizable or ionizable monomer solution into the thermoset or thermoplastic polymer; and polymerizing the non-ionizable or ionizable monomers to form at least two IPNs or semi-IPNs inside the solid form.
Another aspect of the invention provides for a process for preparing a composition of matter comprising at least two IPNs or semi-IPNs from a hydrophobic thermoset or thermoplastic polymer including steps: placing a first section of a solid form of a hydrophobic thermoset or thermoplastic polymer in contact with a first non-ionizable or ionizable monomer solution; diffusing the first non-ionizable or ionizable monomer solution into the thermoset or thermoplastic polymer; polymerizing the first non-ionizable or ionizable monomers to form a first IPN or semi-IPN inside the solid form; placing a second section of the solid form in contact with a second non-ionizable or ionizable monomer solution; diffusing the second non-ionizable or ionizable monomer solution into the thermoset or thermoplastic polymer; and polymerizing the second non-ionizable or ionizable monomers to form a second IPN or semi-IPN inside the solid form.
Various embodiments also include a medical implant comprising a bone interfacing surface, a joint interfacing surface, a first IPN or semi-IPN comprising a non-ionic polymer P and a hydrophobic thermoset or thermoplastic polymer T, and a second IPN or semi-IPN comprising the same said hydrophobic thermoset or thermoplastic polymer T and a hydrophilic interpenetrating polymer S. Optionally, in any of the preceding embodiments, the implant can further include at least two concentration gradients, wherein the non-ionic polymer P forms a first concentration gradient from a first portion of the implant to a second portion of the implant and the hydrophilic interpenetrating polymer S forms a second concentration gradient from a third portion of the implant to a fourth portion of the implant. Optionally, in any of the preceding embodiments, the first concentration gradient in the implant provides an adhesiveness gradient and the second concentration gradient provides a lubricious gradient. In other embodiments, the non-ionic polymer P in the implant is derived from an ethylenically unsaturated monomer without ionizable functional groups.
Optionally, in any of the preceding embodiments, in additional embodiments the non-ionic polymer P in the implant is a constituent of a bone cement. Optionally, in any of the preceding embodiments, the non-ionic polymer P in the implant is selected from the group consisting of polymethylmethacrylate and polystyrene. Optionally, in any of the preceding embodiments, the hydrophobic thermoset or thermoplastic polymer T is a polyurethane polymer. Optionally, in any of the preceding embodiments, the first IPN or semi-IPN exhibits greater adhesiveness, stiffness, or shear strength than the hydrophobic thermoset or thermoplastic polymer T. In further embodiments, the first IPN or semi-IPN exhibits greater adhesiveness than the hydrophobic thermoset or thermoplastic polymer T and the second IPN or semi-IPN exhibits greater lubriciousness than the hydrophobic thermoset or thermoplastic polymer T. Optionally, in any of the preceding embodiments, the medical implant includes first and second gradients that partially or fully overlap. Optionally, in any of the preceding embodiments, the medical implant includes a region on the implant wherein the region is adjacent to the first and second IPN or semi-IPN and does not contain an IPN or semi-IPN.
Another aspect of this invention includes a medical implant comprising a bone interfacing surface, a joint interfacing surface, and at least two IPNs or semi-IPNs, wherein a first IPN or semi-IPN comprises a non-ionic polymer disposed in at least one section of a hydrophobic thermoset or thermoplastic polymer, and a second IPN or semi-IPN comprises a non-ionic polymer disposed in at least one section of the said hydrophobic thermoset or thermoplastic polymer.
The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
The present invention includes a process for modifying common commercially available hydrophobic thermoset or thermoplastic polymers to confer upon them qualities such as lubricity, permeability, conductivity and wear-resistance. Such hydrophobic polymers ordinarily do not soak up water and are generally useful for their mechanical strength, impermeability and insulating ability. An exemplary list of hydrophobic polymers modifiable by the process of this invention includes the following: Acrylonitrile butadiene styrene (ABS), Polymethylmethacrylate (PMMA), Acrylic, Celluloid, Cellulose acetate, Ethylene-Vinyl Acetate (EVA), Ethylene vinyl alcohol (EVAL), Kydex, a trademarked acrylic/PVC alloy, Liquid Crystal Polymer (LCP), Polyacetal (POM or Acetal), Polyacrylates (Acrylic), Polyacrylonitrile (PAN or Acrylonitrile), Polyamide (PA or Nylon), Polyamide-imide (PAI), Polyaryletherketone (PAEK or Ketone), Polyhydroxyalkanoates (PHAs), Polyketone (PK), Polyester, Polyetheretherketone (PEEK), Polyetherimide (PEI), Polyethersulfone (PES)- see Polysulfone, Polyethylenechlorinates (PEC), Polyimide (PI), Polymethylpentene (PMP), Polyphenylene oxide (PPO), Polyphenylene sulfide (PPS), Polyphthalamide (PPA), Polystyrene (PS), Polysulfone (PSU), Polyvinyl acetate (PVA), Polyvinyl chloride (PVC), Polyvinylidene chloride (PVDC), Spectralon, Styrene-acrylonitrile (SAN), Polydimethylsiloxane (PDMS), and Polyurethanes (PU). A wide variety of polyurethanes can be used with varying hard segment, soft segment, and chain extender compositions, as will be described herein.
One aspect of the invention takes advantage of a characteristic of some modifiable thermoset or thermoplastic hydrophobic polymers: The presence of ordered and disordered (amorphous) domains within the polymer. For example, some hydrophobic thermoset or thermoplastic polymers such as polyurethanes are phase-separated, containing first domains of hard segments and second domains of soft segments, with the two domains exhibiting different solubility properties with respect to interpenetration of monomers. In polyurethanes, the hard segments are disposed primarily within the ordered domains and the soft segments are disposed primarily within the disordered (amorphous) domains. (The starting polymer may contain more than two domains, of course, without departing from the scope of the invention.) This difference in properties between the two domains of the phase-separated polymer enables the process of this invention to impart new properties to the polymer that can extend throughout the bulk of the material or throughout only a portion of the material, e.g., in a particular region or in a gradient. For example, a non-lubricious polymer can be made lubricious; an otherwise non-conductive polymer can be made conductive; and an otherwise non-permeable polymer can be made permeable. Moreover, the process can be performed repeatedly to introduce more than one new property to the starting polymer.
In some embodiments, phase separation in the polymer allows for differential swelling of one or more separated phases within the polymer with, e.g., a solvent and/or monomer, which is then used to impart new properties. According to the invention, for example, lubriciousness can be introduced to an otherwise non-lubricious material by adding and polymerizing ionic monomers. In one embodiment, a polymer material with high mechanical strength and a lubricious surface can be made from an otherwise non-lubricious, hydrophobic polymer and a hydrophilic polymer derived from ionizable, vinyl monomers. By converting otherwise hydrophobic materials into biphasic materials with both solid and liquid (water) phases, the present invention addresses a need in the art for lubricious, high strength materials for use in medical, commercial, and industrial applications.
The new properties provided by this IPN depend on the properties of the polymerized monomers that were introduced and on any optional post-polymerization processing. Examples of such new properties include lubriciousness, conductivity, hardness, absorbency, permeability, photoreactivity and thermal reactivity. For example, as shown in
In addition to absorbency, various levels of permeability (water, ion, and/or solute transport) can be introduced into an otherwise non-permeable material. For example, a hydrophobic polymer material such as polyurethane or ABS can be infiltrated with an ionic polymer such as polyacrylic acid and/or poly(sulfopropyl methacrylate) so that it absorbs water, as described above. This hydration of the bulk of the material allows for the transport of solutes and ions. The transport of solutes and ions and permeability to water is made possible by phase continuity of the hydrated phase of the IPN. This is useful in various applications, including drug delivery, separation processes, proton exchange membranes, and catalytic processes. The permeability can also be utilized to capture, filter, or chelate solutes as a liquid flows over or through the material. Furthermore, because of this permeability, the materials of the present invention can be bestowed with increased resistance to creep and fatigue relative to their component hydrophobic polymers due to their ability to re-absorb fluid after sustained or repetitive loading.
Conductivity can be introduced into an otherwise non-conductive material. For example, an insulating polymer material such as polyurethane can be infiltrated with a conductive polymer (a polyelectrolyte) so that at least part of the hybrid material is conductive to electric current.
The invention also includes the alteration of chemical groups of the second polymer and the use of tethering points in the second polymer for another polymer, molecule or biomolecule. Also, any of the domains can be doped with any number of materials, such as antioxidants, ions, ionomers, contrast agents, particles, metals, pigments, dyes, biomolecules, polymers, proteins and/or therapeutic agents.
The first polymer can be additionally crosslinked or copolymerized with the second polymer if, for example, acryloxy, methacryloxy- acrylamido-, allyl ether, or vinyl functional groups are incorporated into one end or both ends of the polyurethane prepolymer and then cured by UV or temperature in the presence of an initiator. For instance, a polyurethane dimethacrylate or polyurethane bisacrylamide can be used in the first network by curing in the presence of a solvent (such as dimethylacetamide) and then evaporating the solvent. The addition of chemical crosslinks (rather than just physical crosslinks) to the IPN adds a level of mechanical stability against creep or fatigue caused by continuous, dynamic loading.
In addition, a multi-arm (multifunctional) polyol or isocyanate can be used to create crosslinks in the polyurethane. In this case, a fully interpenetrating polymer network is created (rather than a semi-interpenetrating polymer network). The result is a composite material with the high strength and toughness of polyurethane and the lubricious surface and biphasic bulk behavior of the poly(acrylic acid). Alternatively, other crosslinking methods can be used, including but not limited to gamma or electron-beam irradiation. These features are especially important for bearing applications such as artificial joint surfaces, or as more biocompatible, thrombo-resistant, long-term implants in other areas of the body such as the vascular system or the skin. Being swollen with water also allows imbibement with solutes such as therapeutic agents or drugs for localized delivery to target areas of the body.
In another embodiment of the present invention, the first polymer can be linked to the second polymer. For example, polyurethane can be linked through a vinyl-end group. Depending on the reactivity ratio between the end group and the monomer being polymerized, different chain configurations can be yielded. For instance, if the reactivity of the monomer with itself is much greater than the end group with the monomer, then the second polymer will be almost completely formed before the addition of the first polymer to the chain. On the other hand, if the reactivity of the monomer and the end group are similar, then a random grafting-type copolymerization will occur. The monomers and end groups can be chosen based on their reactivity ratios by using a table of relative reactivity ratios published in, for example, The Polymer Handbook. The result of these will be a hybrid copolymer/interpenetrating polymer network.
Any number or combinations of ethylenically unsaturated monomers or macromonomers (i.e., with reactive double bonds/vinyl groups) can be used alone or in combination with various solvents and selectively introduced into one or more of the phases of the polymer as long as at least 2% of such monomers is ionizable, i.e., contains carboxylic acid and/or sulfonic acid functional groups. Ethylenically unsaturated monomers with ionizable function groups include acrylic acid (AA) and other sulfonic acid-based monomers. The ethylenically unsaturated aspect of these includes acrylic, methacrylic, acrylamide, allyl ether, etc., as has been disclosed herein. Other monomers include but are not limited to dimethylacrylamide, acrylamide, NIPAAm, methyl acrylate, methyl methacrylate, hydroxyethyl acrylate/methacrylate, and any vinyl-based monomer containing sulfonic acid groups (e.g. acrylamido methyl propane sulfonic acid, vinyl sulfonic acid, 3-sulfopropyl acrylate (or methacrylate), 2-methyl-2-propene-1-sulfonic acid sodium salt 98%, or any monomers in which sulfonic acid is conjugated (allyl ethers, acrylate/methacrylates, vinyl groups, or acrylamides). The monomer can also include any monomers containing carboxylic acid groups conjugated to allyl ethers, acrylate/methacrylates, vinyl groups, or aciylamides. In addition, the monomers can be used in combination, such as both carboxyl acid and sulfonic acid containing monomers, to create a carboxylate/sulfonate copolymer. The pendant functional groups on polymers resulting from these monomers and monomer combinations can be subject to subsequent chemical reactions to yield other functionalities to the final polymer.
In one embodiment, a preformed, thermoplastic polymer may be immersed in acrylic acid (or in a solution of acrylic acid (1% - 100%) or other vinyl monomer solution) along with about 0.1% v/v crosslinker (e.g., triethylene glycol dimethacrylate or N,N methylene bisacrylamide) with respect to the monomer and about 0.1% v/v photoinitiator (e.g. 2-hydroxy-2-methyl propiophenone) with respect to the monomer. The acrylic acid solution can be based on water, salt buffer, or organic solvents such as dimethylacetamide, acetone, ethanol, methanol, isopropyl alcohol, toluene, dichloromethane, propanol, dimethylsulfoxide, dimethyl formamide, or tetrahydrofuran. The polymer may be swollen by the monomer due to solvation of the soft segments in the polymer. The monomer content in the swollen polymer can range from as little as about 1% to up to about 90%.
The monomer-swollen polymer may then be removed, placed in a mold made of glass, quartz, or a transparent polymer, then exposed to IN light (or elevated temperature) to initiate polymerization and crosslinking of the monomers. Alternatively, instead of using a mold, the monomer-swollen polymer can be polymerized while fully or partially exposed to air or an inert atmosphere (e.g., nitrogen or argon), or alternatively in the presence of another liquid such as an oil (e.g., paraffin, mineral, or silicone oil). For medical applications, it is possible that polymerization step can be performed in vivo without a mold.
Depending on the initiator used, exposure to UV light, IR, or visible light, a chemical, electrical charge, or elevated temperature leads to polymerization and crosslinking of the ionizable monomers within the hydrophobic polymer. As an example, acidic monomers (e.g. acrylic acid) are polymerized to form an ionic polymer within a preformed thermoplastic, hydrophobic matrix, forming an interpenetrating polymer network (“IPN”). Solvents can be extracted out by heat and convection or by solvent extraction. Solvent extraction involves the use of a different solvent (such as water) to extract the solvent from polymer, while heat or convection relies upon evaporation of the solvent. Depending on the pKa of the ionic polymer (e.g., pKa of PAA=4.7), an acidic pH would leave the ionic polymer more protonated while a more basic pH would leave it more ionized.
Swelling of the IPN in aqueous solution such as phosphate buffered saline (or other buffered salt solution) at neutral pH will lead to ionization of the poly(acrylic acid) and further swelling with water and salts. The resulting swollen IPN will have a lubricious surface conferred by the hydrophilic, charged poly(acrylic acid) and high toughness and mechanical strength conferred by the thermoplastic. In the case of a polyurethane-based IPN, the IPN will have a structure in which crystalline hard segments in the polyurethane act as physical crosslinks in the first network, while chemical crosslinks will be present in the second network.
The materials can also be crosslinked after synthesis using gamma radiation or electron beam radiation. In one example, polyurethane/polyacrylic acid can be synthesized and then crosslinked by gamma irradiation, for instance with doses of, for example, 5, 10, 15, 20, or 25 kGy. In this case, the polymerization of polyacrylic acid would be done in the absence of a crosslinker, and after formation of the polymer blend (physical IPN), the material would be exposed to gamma radiation. This would have the dual purpose of sterilizing and crosslinking the polyurethane. It is known in the art that crosslinking of poly(acrylic acid) hydrogels using gamma irradiation shows a dose-dependence to the crosslinking of the polymer. This process can also be applied to other combinations of first and second network polymers, e.g., polyurethane and polymethyl methacrylate, ABS and polyacrylic acid, etc.
In addition to the starting thermoset and thermoplastic hydrophobic polymers identified above, modifications to and derivatives of such polymers may be used, such as sulfonated polyurethanes. In the case of the polyurethanes, the polyurethane polymer can be a commercially available material, a modification of a commercially available material, or be a new material. Any number of chemistries and stoichiometries can be used to create the polyurethane polymer. For the hard segment, isocyanates used are 1,5 naphthalene diisocyanate (NDI), isophorone isocyanate (IPDI), 3,3-bitoluene diisocyanate (TODI), methylene bis (p-cyclohexyl isocyanate) (H12HDI), cyclohexyl diiscocyanate (CHDI), 2,6 tolylene diisocyanate or 2,4 toluene diisocyanate (TDI), hexamethyl diisocyanate, or methylene bis(p-phenyl isocyanate). For the soft segment, chemicals used include, for example polyethylene oxide (PEO), polypropylene oxide (PPO), poly(tetramethylene oxide) (PTMO), hydroxy terminated butadiene, hydroxybutyl terminated polydimethylsiloxane (PDMS), polyethylene adipate, polycaprolactone, polytetramethylene adipate, hydroxyl terminate polyisobutylene, polyhexamethylene carbonate glycol, poly(1,6 hexyl 1,2-ethyl carbonate, and hydrogenated polybutadiene. Any number of telechelic polymers can be used in the soft segment, if end-groups that are reactive with isocyanates are used. For instance, hydroxyl- or amine- terminated poly(vinyl pyrrolidone), dimethylacrylamide, carboxylate or sulfonated polymers, telechelic hydrocarbon chains (with hydroxyl and/or amine end groups), dimethylolpropionic acid (DMPA), or these in combination with each other or with other soft segments mentioned above (e.g., PDMS) can be used. Ionic soft segments (or chain extenders) such as dihydroxyethyl propionic acid (DMPA) (or its derivatives) can be used to make a water-dispersible polyurethane, so long as the ionic chain extender does not comprise more than 2% of the material.
Chain extenders include, for example, 1,4 butanediol, ethylene diamine, 4,4′methylene bis (2-chloroaniline) (MOCA), ethylene glycol, and hexane diol. Any other compatible chain extenders can be used alone or in combination. Crosslinking chain extenders can be used containing isocyanate-reactive endgroups (e.g. hydroxyl or amine) and a vinyl-based functional group (e.g. vinyl, methacrylate, acrylate, allyl ether, or acrylamide) may be used in place of some or all of the chain extender. Examples include 1,4 dihydroxybutene and glycerol methacrylate. Alternatively, crosslinking can be achieved through the use of a polyol such as glycerol which contains greater than two hydroxyl groups for reaction with isocyanates.
In some embodiments, at least 2% of the hydrophilic monomers in the second network is ionizable and anionic (capable of being negatively charged). In one such embodiment, poly(acrylic acid) (PAA) hydrogel is used as the second polymer network, formed from an aqueous solution of acrylic acid monomers. Other ionizable monomers include ones that contain negatively charged carboxylic acid or sulfonic acid groups, such as methacrylic acid, 2-acrylamido-2-methylpropanesulfonic acid, sulfopropyl methacrylate (or acrylate), vinyl sulfonic acid, or vinyl-conjugated versions of hyaluronic acid, heparin sulfate, and chondroitin sulfate, as well as derivatives, or combinations thereof. The second network monomer may also be positively charged or cationic. These other monomers can also be in a range of 1%-99% in either water or organic solvent, or be pure (100%). One embodiment of the monomer used to form the second network can be described by the following characteristics: (1) it is capable of swelling the polyurethane, (2) capable of polymerizing, and (3) is ionizable.
Other embodiments use a co-monomer in addition to the ionic polymer that may be non-ionic, such as acrylamide, methacrylamide, N-hydroxyethyl acrylamide, N-isopropylacrylamide, methylmethacrylate, N-vinyl pyrrolidone, 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate or derivatives thereof. These can be copolymerized with less hydrophilic species such as methylmethacrylate or other more hydrophobic monomers or macromonomers. These can also be polymerized alone or copolymerized with the aforementioned hydrophilic and/or ionizable monomers.
Crosslinked linear polymer chains (i.e., macromolecules) based on these monomers may also be used in the second network, as well as biomacromolecules (linear or crosslinked) such as proteins and polypeptides (e.g., collagen, hyaluronic acid, or chitosan). The choice of the second material will depend on the target application, for instance in orthopaedic applications, hyaluronic acid may be useful because it is a major component of joint cartilage. In addition, biological molecules may carry certain benefits such as intrinsic biocompatibility or therapeutic (e.g., wound healing and/or antimicrobial) properties that make them useful as material components.
Any type of compatible cross-linkers may be used to crosslink the second network in the presence of any of the aforementioned first networks such as, for example, ethylene glycol dimethacrylate, ethylene glycol diacrylate, diethylene glycol dimethacrylate (or diacrylate), triethylene glycol dimethacrylate (or diacrylate), tetraethylene glycol dimethacrylate (or diacrylate), polyethylene glycol dimethacrylate, or polyethylene glycol diacrylate, methylene bisacrylamide, N,N′-(1,2-dihydroxyethylene)bisacrylamide, derivatives, or combinations thereof. Any number of photoinitiators can also be used depending on their solubility with the precursor solutions/materials. These include, but are not limited to, 2-hydroxy-2-methyl-propiophenone and 2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-propanone. In addition, other initiators such as benzoyl peroxide, 2-oxoglutaric acid, azobisisobutyronitrile, or potassium persulfate (or sodium persulfate) can be used. For instance, benzoyl peroxide is useful for temperature-initiated polymerizations, while azobisisobutyronitrile and sodium persulfate are useful as radical initiators.
In another embodiment, a solvent can be used as a “trojan horse” to deliver monomers that otherwise would not mix (or solubilize with) the polymer to one (or more) phases of the polymer. The solvent must be carefully chosen based on the specific qualities and phases of the polymer and monomers. For instance, acetic acid is capable of swelling but does not dissolve many polyurethanes. Therefore, acetic acid can be used to carry other monomers such an acrylamide solution, that otherwise would not enter polyurethane, into the bulk of the polyurethane. This allows the acrylamide to be selectively polymerized inside one phase of the polyurethane. The acetic acid can then be washed out leaving behind a polyurethane with one or more new properties. Other solvents that can be used include, but are not limited to, dichloromethane, methanol, propanol, butanol, (or any alkyl alcohol), acetone, dimethylacetamide, dimethylformamide, dimethylsulfoxide, tetrahydrofuran, diethylether, or combinations of these. Taking into account the solubilities in the phases of the polymer, solvents with varying degrees of swelling of one can be chosen. Solubilities of the solvents and components of the material to be swollen can be obtained from polymer textbooks such as The Polymer Handbook or can be measured experimentally.
The present invention can be used to form a bulk-interpenetrated coating on a polymeric material. This coating is inextricably entangled with the underlying polymer matrix, and is in contrast to conventional surface coatings in which a material is grafted or tethered to a surface. In one example of a bulk-interpenetrated coating, a thermoplastic polymer is coated on one or more sides or is immersed in an ionizable monomer such as acrylic acid in the presence of a photoinitiator and a crosslinking agent. The thermoplastic is then placed in a mold and then exposed to an initiator (e.g., UV light or heat) for a predetermined period of time. The mold can be fully or partially transparent and/or masked to facilitate regionally specific curing of the monomer. The modified material is then immersed in buffered saline solution to neutralize the ionic polymer and render the surface lubricious and hydrophilic. The modified plastic can then be further remolded by application of heat, solvent, and/or pressure and then shaped to the desired dimensions. The modified plastic can then be bonded to various surfaces such as metal, glass, plastic, or other materials by applying heat or solvent (such as acetone) to the unmodified plastic surface and bringing the surface in contact with the surface of interest.
Among the applications of the invention are the creation of hydrophilic, lubricious sidings or coatings to reduce drag and/or biofilm formation and/or barnacle formation in marine vessels, diving or swimming suits, other water crafts or water-borne objects, or pipes. In addition, the invention can be used as a method for making bearings and moving parts for applications such as engines, pistons, or other machines or machine parts. The invention can also be used in artificial joints systems or long-term implants in other areas of the body, such stents and catheters for the vascular or urinary system or implants, patches, or dressings for the skin.
In one embodiment, a TP/PAA IPN can be created in a gradient if polyurethane (“PU”) is swollen in AA on one side only or if the swelling time is limited such that diffusion of the monomers through the bulk of the TP is not complete. This is especially useful in the creation of osteochondral grafts for orthopaedic joint replacement materials. For instance, in the case of a cartilage replacement material, one side of the material is made lubricious and water swollen, while the other remains a solid (pure thermoplastic). In between is a transition between a TP/PAA IPN and TP, with decreasing PAA content from one surface to the other. Alternatively, bulk materials with a TP/PAA IPN outer aspect and PU-only “core” can be made if the diffusion of AA into the TP is precisely controlled by timing the infiltration of the monomers into the bulk. The differential swelling that results from this configuration can lead to remaining stresses (compressive on the swollen side, tensile on the non-swollen side) that can help enhance the mechanical and fatigue behavior of the material. In the case of a material with a thickness gradient, the base of thermoplastic-only material can be used for anchoring, adhering, or suturing the device to the anatomical region or interest. This base can be confined to a small area or be large (e.g., a skirt) and can extend outward as a single component or multiple components (e.g., straps). The internal stresses built up within the thermoplastic during processing or after swelling can be reduced by temperature-induced annealing. For instance, temperatures of 60-120 degrees Celsius can be used for various times (30 minutes to many hours) to anneal the polymer, and the heat can be applied in an oven, by a hot surface, by radiation, or by a heat gun. The thermoplastic can later be crosslinked using, for example, gamma or electron beam radiation.
Articles made from the IPN's and semi-IPN's of this invention may also be formed in a laminate structure, as illustrated in
Articles formed from the gradient or homogeneous IPN's and semi-IPN's of this invention may be shaped as desired.
As shown in
Shaping of IPN and semi-IPN articles according to this invention may be formed in situ, such as within a human body. For example,
Shaped or unshaped IPN and semi-IPN articles made according to this invention may be attached to other surfaces.
The composition of this invention, formed, e.g., by the method of this invention, may be used in a variety of settings. One particular use is as artificial cartilage in an osteochondral graft. The present invention provides a bone-sparing arthroplasty device based on an interpenetrating polymer network that mimics the molecular structure, and in turn, the elastic modulus, fracture strength, and lubricious surface of natural cartilage. Emulating at least some of these structural and functional aspects of natural cartilage, the semi-IPNs and IPNs of the present invention form the basis of a novel, bone-sparing, “biomimetic resurfacing” arthroplasty procedure. Designed to replace only cartilage, such a device is fabricated as a set of flexible, implantable devices featuring lubricious articular surfaces and osteointegrable bone-interfaces.
In principle, the device can be made for any joint surface in the body. For example, a device to cover the tibial plateau will require an analogous bone-preparation and polymer-sizing process. For a device to cover the femoral head in the hip joint, a cap shaped device fits snugly over the contours of the femoral head. For a device to line the acetabulum, a hemispherical cup-shaped device stretches over the lip and can be snapped into place in the socket to provide a mating surface with the femoral head. In this way, both sides of a patient's hip joint can be repaired, creating a cap-on-cap articulation. However, if only one of the surfaces is damaged, then only one side may be capped, creating a cap-on-cartilage articulation. In addition, the materials of the present invention can be used to cap or line the articulating surfaces of another joint replacement or resurfacing device (typically comprised of metal) to serve as an alternative bearing surface.
To create a cap-shaped device using the present invention for the shoulder joint (also a ball-and-socket joint), a process similar to that of the hip joint is used. For instance, a shallow cup can be created to line the inner aspect of the glenoid. Furthermore, devices for other joints in the hand, fingers, elbow, ankles, feet, and intervertebral facets can also be created using this “capping” concept. In one embodiment in the distal femur, the distal femur device volume follows the contours of the bone while sparing the anterior and posterior cruciate ligaments.
In one embodiment of prosthetic cartilage formed according to this invention, a polyether urethane device pre-formed with shore hardness of 75D is injection molded. This device is then solution casted in a Vitamin E-containing solution containing polyether urethane formulated to a dry shore hardness of 55D (e.g., 25% Elasthane™ 55D in dimethylacetamide). The casted layer may then be dried in a convection oven to remove the solvent. The device may then be immersed in a solution of acrylic acid, photoinitiator, and crosslinker for 24 hours, and then placed over a glass mold and exposed to UV light. The resulting device may then be soaked and washed in phosphate buffered saline. This process is used to create either convex or concave devices for arthroplasty applications. The injection-molded pre-form has on one of its sides a plurality of spaces (pores or features) that make capable of being anchored to bone with traditional orthopaedic bone cement.
Although a commercially available polyurethane product, Elasthane, Bionate, Pursil, or Sylgard, was used in some examples, it is understood in the art that any suitable hydrophobic thermoset/thermoplastic polymer or material may be used and there is no limitation as to the particular commercial products/tradenames described herein.
In another embodiment of the device, a polycarbonate urethane pre-formed with surface features on one side is fabricated, followed by dip-casting of one of its sides in a solution of polyether urethane and then subjected to a process similar to the one above. In still another embodiment, a polyether urethane pre-form of shore hardness 55D (e.g., Elasthane™ 55D) is injection molded, followed by immersion in a monomer solution as above. After curing of the second polymer network, the device is dip-casted on one side with polycarbonate urethane of shore hardness 75D. In any of these embodiments, additional surface features can be added to the bone interface side of the device through a number of means, including but not limited to machining (lathe and end-mill), solution casting, solvent-welding, ultrasonic welding, or heat-welding.
Porous polycarbonate urethane IPN and semi-IPN structures may be made according to this invention. Particles (size range: 250-1500 μm) of polycarbonate urethane, including but not limited to Bionate® 55D, Bionate® 65D, and Bionate® 75D, may be sintered in a mold using heat (220-250° C.), pressure (0.001-100 MPa) , and/or solvent for 10-30 min. The structures will have a final pore size of 50-2000 μm, porosity of 15-70%, and a compressive strength exceeding 10 MPa. The final structures will have porosity to promote tissue ingrowth/integration for medical and veterinary applications. This construct can be used alone or with an overlying bearing surface made from any of the lubricious polymers described in this invention. This material could be used as a cartilage replacement plug in joints of the body where cartilage has been damaged, as described below.
The composition of this invention, made, e.g., according to the method of this invention, may be used as a fully or partially synthetic osteochondral graft. The osteochondral graft consists of a lubricious, cartilage-like synthetic bearing layer that may be anchored to porous bone or a synthetic, porous bone-like structure. The bearing layer has two regions: a lubricious surface layer and a stiff, bone anchoring layer. In one embodiment, the top, lubricious region of the bearing layer consists of an interpenetrating polymer network that is composed of two polymers. The first polymer may be a hydrophobic thermoplastic with high mechanical strength, including but not limited to polyether urethane, polycarbonate urethane, silicone polyether urethane, and silicone polycarbonate urethanes, or these materials with incorporated urea linkages, or these materials with incorporated urea linkages (e.g. polyurethane urea). The second polymer may be a hydrophilic polymer derived from ionizable, vinyl monomers, including but not limited to acrylic acid and/or sulfopropyl methacrylate. The bottom region of the bearing layer (bone anchoring layer) may be a stiff, non-resorbable thermoplastic that can be caused to flow with ultrasonic welding vibration, ultrasonic energy, laser energy, heat, RF energy and electrical energy. The bone anchoring layer is used to anchor the bearing layer to bone or a bone-like porous structure. If porous bone is used, it can be cancellous bone from a human or animal. If a synthetic bone-like material is used, it can consist of porous calcium-phosphate (and/or other materials, including but not limited to porous carbonated apatite, beta-tricalcium phosphate, or hydroxyapatite), or a porous resorbable or non-resorbable thermoplastic as described above, including but not limited to polycarbonate urethane, polyether urethane, PLA, PLLA, PLAGA, and/or PEEK. The bearing layer is anchored to the porous bone or bone-like structure via application of pressure combined with energy that cause the bone anchoring material to melt and flow into the pores or spaces of the bone or bone-like structure, after which the energy source is removed and the material resolidifies. The energy source can include but is not limited to vibration, ultrasonic energy, laser energy, heat, RF energy, and electrical energy.
The following figures illustrate various embodiments of the present invention as a device to partially or completely resurface damaged joints in the body of mammals (animals or human). These devices can be fixated to bone through any number of means, such as a press-fit, screws (metal or plastic, either resorbable or nonresorbable), sutures (resorbable or nonresorbable), glue, adhesives, light-curable adhesives (e.g. polyurethane or resin-based), or cement (such as polymethylmethacrylate or calcium phosphate, or dental cements).
Implants and other articles may be made in a variety of complex shapes according to the invention.
Osteochondral grafts may also be used in other joints, such as in the finger, hand, ankle, elbow, feet or vertebra. For example,
The IPN's and semi-IPN's compositions of this invention may be formed as prosthetic cartilage plugs for partial resurfacing of joint surfaces.
Screw holes may be provided to the osteochondral graft for fixation to the bone. In
In
Many of the osteochondral grafts and other implants described above are affixed to a single bone surface.
The invention has non-medical applications. For example,
The materials of the present invention have utility in applications requiring electrochemical conductivity. The conductivity of the IPNs and semi-IPNs is based on the flow of ions through the hydrated matrix of the material. Thin films of polyetherurethane were swelled with four different compositions of an acrylic acid and water mixture (15, 30, 50, and 70% acrylic acid in water). Each swelled film was then cured in UV light to form the semi-IPN. The films were then neutralized in PBS. The electrical resistance of the materials was measured using an ohm meter. To measure resistance, the IPN film was lightly patted with a paper towel to remove excess PBS and the ohm meter probes were clipped to the film across a film width of 60-70 mm. The initial and steady-state resistance values were recorded. In addition, the resistances of an unmodified polyetherurethane film and liquid PBS were measured. The resistance of PBS was measured by placing the ohm meter probes directly into a PBS bath at an approximate distance of 60 mm between the probes. Resistance measurements are in the following Table.
The results show that the resistances of the semi-IPNs are lower than (but within the same order of magnitude as) pure PBS fluid alone. The limit of the ohm meter was 40,000 ohms. Typical values for insulators (including polyurethanes) are 1014-1016 ohms; therefore, the resistance values of the PEU alone were outside the range of the meter used. Permeability of the PEU/PAA semi-IPN was measured using a device similar to the one described by Maroudas et al. in Permeability of articular cartilage. Nature, 1968. 219(5160): p. 1260-1. The permeability was calculated according to Darcy's Law (Q =KAΔp/L), where Q is the flow rate [mm3/sec], A the cross-sectional area of the plug [mm2], Δe pressure gradient applied [MPa] (pressurized fluid), L is the thickness of the hydrogel. The permeability of the PEU/PAA semi-IPN prepared from 70% acrylic acid was found to be K=1.45×10−17 m4/N*sec. For natural cartilage, literature values range from 1.5×10−16 to 2×10−5 m4/N*sec. Therefore, the PEU/PAA is 10-100 times less permeable than cartilage, which may make it less prone to dehydration under prolonged compressive loads compared to natural cartilage. The permeability of the IPN can be tuned by varying the concentration of AA in the swelling solution; the higher the AA content, the higher the permeability. In contrast, the unmodified PEU material alone is effectively impermeable to solutes; although it retains some moisture (=1%), in practice it does not act as a solute-permeable matrix.
Other variations and modifications to the above compositions, articles and methods include:
The first polymer can be one that is available commercially or custom-made and made by a number of ways (e.g., extruded, injection molded, compression molded, reaction injection molded (RIM) or solution-casted.) The first polymer can be uncrosslinked or crosslinked by various means. Either polymer can be crosslinked by, e.g., gamma radiation or electron beam radiation.
Any number or combinations of ethylenically unsaturated monomers with ionizable groups or macromonomers (e.g., containing reactive double bonds) can be used as the basis of the second or subsequent network so long as the total contains at least 2% by weight ionizable chemical groups. These include but are not limited those containing vinyl, acrylate, methacrylate, allyl ether, or acrylamide groups. Any number of pendant functional groups can be conjugated to these ethylenically unsaturated groups including but not limited to carboxylic acid, sulfonic acid, acetates, alcohols, ethers, phenols, aromatic groups, or carbon chains.
The polyurethane-based polymer can be (but is not limited to) the following: polyether urethane, polycarbonate urethane, polyurethane urea, silicone polyether urethane, or silicone polycarbonate urethane. Other polyurethanes with other hard segments, soft segments, and chain extenders are possible.
Other polymers can be used in the first network, such as homopolymers or copolymers of silicone (polydimethylsiloxane) or polyethylene.
When a polyurethane-based polymer is used as the first polymer, the extent of physical and chemical crosslinking of the polyurethane-based polymer can be varied between physical crosslinking-only (thermoplastic) to extensive chemical crosslinking. In the case of chemical crosslinking, the crosslinkable polyurethane can be used alone or as a mixture with thermoplastic (uncrosslinked) polyurethane.
The conditions of polymerization (i.e., ambient oxygen, UV intensity, UV wavelength, exposure time, temperature) may be varied.
The orientation and steepness of the composition gradients can be varied by various means such as time and/or method of immersion in the monomer, and the application of external hydrostatic positive or negative pressure.
The thermoplastic can be made porous by various techniques such as foaming or salt-leaching. After swelling of the porous polymer (such as PU) with a monomer (such as AA) followed by polymerization or AA, a porous IPN is formed.
Additional layers of thermoplastics can be added to material on either the IPN side or the thermoplastic side-only by curing or drying the new thermoplastic to the surface. The layers can all be the same material or be different materials (e.g. ABS+polyurethane, polyether urethane+polycarbonate urethane, etc.
A number of different solvents can be used during the synthesis of the polyurethane, the second network, or both, including but not limited to dimethylacetamide, tetrahydrofuran, dimethylformamide, ethanol, methanol, acetone, water, dichloromethane, propanol, methanol, or combinations thereof.
Any number of initiators can be used such as photoinitiators (e.g., phenone-containing compounds and Irgacure® products), thermal initiators, or chemical initiators. Examples of thermal initiators include but are not limited to azo-compounds, peroxides (e.g., benzoyl peroxide), persulfates (e.g., potassium persulfate or ammonium persulfate), derivatives, or combinations thereof.
Variations of the crosslinking identity and density (e.g. 0.0001% -25% by mole crosslinking agent with respect to the monomer), initiator concentration (e.g. 0.0001% -10% by mole with respect to the monomer) molecular weight of precursor polymers, relative weight percent of polymers, light wavelength (UV to visible range), light intensity (0.01 mW/cm2-1 W/cm2), temperature, pH and ionic strength of swelling liquid, and the level of hydration.
The second network material can be synthesized in the absence of a crosslinking agent.
The water content of these materials can range between 2% to 99%.
Different components of the IPN can be incorporated in combination with ionizable monomers, such as poly(vinyl alcohol), poly(ethylene glycol)-acrylate, poly(2-hydroxyethylacrylate), poly(2-hydroxyethylmethacrylate), poly(methacrylic acid), poly(2-acrylamido-2-methyl propane sulfonic acid), other vinyl-group containing sulfonic acids, poly(acrylamide), poly(N-isopropylacrylamide)poly(dimethacrylamide), and combinations or derivatives thereof. For instance, a copolymer of acrylic acid and vinyl sulfonic acid or 2-acrylamido-2-methyl propane sulfonic acid can be created for the second network to form a polyurethane first network and a poly(acrylic acid-co-acrylamido-methyl-propane sulfonic acid) copolymeric second network. Any monomer or combination of monomers can be used in conjunction with a suitable solvent as long as they contain at least 2% by weight ionizable monomer and are able to enter (swell) the first polymer.
The IPN can have incorporated either chemically or physically within its bulk or its surface certain additives such as antioxidants (e.g., Vitamin C, Vitamin E, Irganox®, or santowhite powder) and/or anti-microbial agents (e.g., antibiotics). These can be chemically linked to the material by, for example, esterification of the anti-oxidant with any vinyl-group containing monomer such as methacrylate, acrylate, acrylamide, vinyl, or ally! ether.
More than two networks (e.g., three or more) can also be formed, each of which are either crosslinked or uncrosslinked.
The polyurethane itself can be modified in a number of ways, such as by sulfonation at the urethane group by reaction of 1,3 propane sulfone in the presence of sodium hydride, or the formation of allophanate linkages at the urethane group by reaction with excess isocyanate groups. For instance, excess isocyanatoethyl methacrylate can be reacted with polyurethane in toluene in the presence of dibutyltin dilaurate for 2.5 hours to yield a methacryloxy-conjugated polyurethane surface. The methacryloxy groups can then be used subsequently tether other methacryloxy (or other vinyl group)-containing monomers or macromonomers via free radical polymerization. Such modifications can be carried out before or after the formation of the second network of the IPN. Other modifications will be apparent to those skilled in the art.
In one example, a polycarbonate urethane (Bionate 55D) was immersed in 70% acrylic acid in water containing 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% v/v triethylene glycol dimethacrylate with respect to the monomer overnight. The polycarbonate urethane was removed from the solution, placed between two glass slides, and exposed to UV light (2 mW/cm2) for 15 minutes. The resulting semi-IPN was removed, and washed and swollen in phosphate buffered saline. The material swelled and became lubricious within hours. In other examples, segmented polyurethane urea, as well as silicone polyether urethane and silicone polycarbonate urethanes were placed in acrylic acid solutions and polymerized and washed in the same fashion to yield a lubricious IPN.
In another example, a polyether urethane (Elasthane™ 55D) was immersed in 70% acrylic acid in water containing 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% v/v triethylene glycol dimethacrylate with respect to the monomer overnight. The polyether urethane was removed from the solution, placed between two glass slides, and then exposed to UV light (2 mW/cm2) for 15 minutes. The resulting semi-IPN was removed and then washed and swollen in phosphate buffered saline. The material swelled and became lubricious within hours. In other examples, polycarbonate urethane, segmented polyurethane urea, as well as silicone polyether urethane and silicone polycarbonate urethanes were placed in acrylic acid solutions and polymerized and washed in the same fashion to yield lubricious IPNs.
In another example, silicone polyether urethane and silicone polycarbonate urethanes were separately placed overnight in 100% acrylic acid solutions, to which were added 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% v/v triethylene glycol dimethacrylate with respect to the monomer. After polymerization and crosslinking, the semi-IPNs swelled and became lubricious. The addition of silicone (polydimethylsiloxane) in the polyurethane adds an extra level of biostability to the material as well as potentially useful surface chemistry and properties.
In another example, a methacryloxy-functionalized polycarbonate urethane was exposed to UV light to crosslink the polycarbonate urethane, and then swollen in 70% acrylic acid with 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% v/v triethylene glycol dimethacrylate with respect to the monomer overnight. The material was removed from the solution, placed between two glass slides, and then exposed to UV light (2 mW/cm2) for 15 minutes to yield a fully interpenetrating polymer network of the polycarbonate urethane and poly(acrylic acid.) The IPN was then washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
In another example, a methacryloxy-functionalized polyether urethane was exposed to UV light (in the presence of 0.1% 2-hydroxy-2-methyl propiophenone and 0.1% triethylene glycol dimethacrylate) to crosslink the polyetherurethane, and then was swollen in 70% acrylic acid with the aforementioned photoinitiator and crosslinker followed by UV-initiated crosslinking to yield a fully interpenetrating polymer network of the polyetherurethane and poly(acrylic acid.) The IPN was then washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
In another example, a 25% solution of methacryloxy-functionalized polycarbonate urethane in DMAC along with 0.1% of the aforementioned photoinitiator was exposed to UV light to crosslink the polycarbonate urethane. After removing the solvent in a heated (60° C.) convection oven, an additional layer of polycarbonate urethane was then cast on one side of the crosslinked polycarbonate urethane to yield a laminate structure and then only the crosslinked side was swollen in 70% acrylic acid with the 0.1% 2-hydroxy-2-methyl propiophenone and 0.1% triethylene glycol dimethacrylate followed by UV-initiated crosslinking to yield a fully interpenetrating polymer network of the polycarbonate urethane and poly(acrylic acid.) The IPN was then washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
In another example, a 25% solution of methacryloxy-functionalized polycarbonate urethane in DMAC along with 0.1% of the aforementioned photoinitiator was exposed to UV light to crosslink the polyether urethane. After removing the solvent in a heated (60° C.) convection oven, an additional layer of polyether urethane was then cast on one side of the crosslinked polycarbonate urethane to yield a laminate structure and then only the crosslinked side was swollen in 70% acrylic acid with 0.1% 2-hydroxy-2-methyl propiophenone and 0.1% triethylene glycol dimethacrylate followed by UV-initiated crosslinking to yield a fully interpenetrating polymer network of the polyether urethane and poly(acrylic acid.) The IPN was then washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
In another set of examples, a layer of methacroxy-functionalized polyether urethane was cast onto a layer of injection molded polyether urethane, and separately, another layer was cast onto a layer of injection molded polycarbonate urethane. Each was exposed to UV light, to yield laminate structures. Only the crosslinked sides were swollen in 70% acrylic acid with 0.1% 2-hydroxy-2-methyl propiophenone and 0.1% triethylene glycol dimethacrylate followed by UV-initiated crosslinking to yield a fully interpenetrating polymer networks. The IPNs were then washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
In one example, acrylonitrile butadiene styrene (ABS) was exposed to 100% acrylic acid in water containing 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% v/v triethylene glycol dimethacrylate with respect to the monomer for 15 minutes. The surface-exposure was accomplished by drop-casting the monomer solution on the surface of the ABS for 30 minutes. The ABS was then placed between two glass slides, and then exposed to UV light (2 mW/cm2) for 15 minutes. The resulting ABS/PAA gradient IPN was removed and then washed and swollen in phosphate buffered saline. The IPN was washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers. The material swelled and became lubricious within hours.
To reshape the thermoplastic gradient IPNs, heat was applied. An ABS/PAA gradient IPN was heated using a heat gun and then laid on a cylindrical polypropylene tube. After letting the material cool to room temperature, acetone was injected between the ABS/PAA and the polypropylene. After applying manual pressure and allowing the sample to dry, the result was a thermoplastic gradient IPN wrapped around and bonded to a polypropylene tube.
In another example, a thermoplastic gradient ABS/PAA IPN was attached to polycarbonate urethane by injecting acetone between the ABS and polycarbonateurethane and applying manual pressure to yield a thermoplastic gradient IPN bonded to a polycarbourethane.
In another example, a curved polycarbonate urethane IPN was made straight again by applying heat on the polyurethane side using a heat gun, manually reversing the curvature of the material, and cooling the IPN in water.
In another example, a polyether urethane solution (e.g. 20% in dimethylacetamide (“DMAC”)) was cast on top of a polycarbonate urethane in a laminate structure, allowed to dry in a heated (60° C.) convection oven, and then only the polyether urethane surface was exposed to 70% acrylic acid in water containing 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% v/v triethylene glycol dimethacrylate with respect to the monomer for 15 minutes. The surface-exposure was accomplished by laying the laminate material polyether urethane-side down on a bed of fabric that was soaked in the aforementioned monomer solution. The material was removed from the fabric mat, placed between two glass slides, and then exposed to UV light (2 mW/cm2) for 15 minutes. The resulting gradient semi-IPN was removed, washed and swollen in phosphate buffered saline. The material swelled and became lubricious within hours. In other examples, polyether urethane, segmented polyurethane urea, silicone polyether urethane, and silicone polycarbonate urethane were handled the same way to yield a lubricious semi-IPNs.
In another example, a layer of polycarbonate urethane (20% in DMAC) containing 50% by weight sodium chloride was solution cast on a premade polyether urethane-polycarbonate urethane and dried at 80° C. under convection. The salt was washed away in water to yield a porous side on the laminated polyurethane. Other materials have been made with sodium chloride concentrations varying between 10% and 80%
In another example, a layer of polycarbonate urethane (20% in DMAC) containing 20% tricalcium phosphate was solution cast on a premade polyether urethane-polycarbonate urethane and dried at 80° C. under convection. The tricalcium phosphate was left embedded within the polyurethane as an osteoconductive agent. Other materials have been made with tricalcium phosphate concentrations varying from 0.001% - 20%
In another example, a polyurethane urea (e.g. 20% in dimethylacetamide) was cast on top of a polycarbonate urethane in a laminate structure, and then only the polyurethane urea surface was exposed to 70% acrylic acid in water containing 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% v/v triethylene glycol dimethacrylate with respect to the monomer for 15 minutes. The surface-exposure was accomplished by laying the laminate material polyurethane urea-side down on a bed of fabric that was soaked in the aforementioned monomer solution. The polycarbonate urethane was removed from the fabric mat, placed between two glass slides, and then exposed to UV light (2 mW/cm2) for 15 minutes. The resulting gradient semi-IPN was removed and then washed and swollen in phosphate buffered saline. The material swelled and became lubricious within hours. The material was washed in PBS to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
In another example, a methacryloxy-functionalized polyether urethane mixed with a thermoplastic polyether urethane in solution (25% in dimethylacetamide) was exposed to UV light to crosslink the polycarbonate urethane. An additional layer of polyether urethane was then cast on one side of the crosslinked polyether urethane to yield a laminate structure and then only the crosslinked side was swollen in 70% acrylic acid with the aforementioned photoinitiator and crosslinker, followed by UV-initiated crosslinking to yield a fully interpenetrating polymer network of the polyether urethane and poly(acrylic acid.) The IPN was then washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
In one example, flat sheets were created by solution casting of thermoplastic polyurethanes in (dimethylacetamide (DMAC). Polyurethane solutions of polyether urethane (Elasthane™), polycarbonate urethane (Bionate), polyether urethane urea (Biospan), silicone polycarbonate urethane (Carbosil), and silicone polyether urethane (Pursil) were synthesized in dimethylacetamide (DMAC) at solids concentrations of about 25% by the manufacturer.
Spherical shapes were cast by dip-coating glass as well as silicone spheres in polyurethane solutions (in DMAC). Polycarbonate urethane (20% in DMAC) was dip coated onto a spherical glass mold (49.5 mm outer diameter), and separately, onto a silicone sphere. The solvent was removed by drying at 80° C. in a convection oven. This process was repeated two more times to create three total coatings. Then, the sphere was dip coated in polyether urethane (20% in DMAC) and then dried at 80° C. under convection. This process was also repeated two more times. The resulting capped-shaped, laminate polyurethane was removed from the mold, and its outer side immersed in a 70% acrylic acid solution in water, with 0.1% 2-hydroxy-2-methyl-propiophenone and 0.1% triethylene glycol dimethacrylate for 1.5 hours. The cap was inverted, placed back over a spherical glass mold, and exposed to UV light (2 mW/cm2) for 15 minutes. Next the cap was removed from the mold and placed in phosphate buffered saline. The result was a spherical, gradient IPN with one lubricious surface and one pure thermoplastic surface. Other temperatures and other solvents can also be used to carry out this process, as well as other mold materials and polymer components.
In another example, a polyether urethane was swollen in 70% acrylic acid with 0.1% 2-hydroxy-2-methyl propiophenone and 0.1% methylene bisacrylamide. One side of the material was dabbed dry, and then exposed to air and treated with UV light. The resulting gradient semi-IPN was then washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers. In other experiments, the material was exposed to nitrogen or argon during curing.
In another example, a polyether urethane (Elasthane™ 55D) was injection molded and then swollen in 70% acrylic acid with 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% w/w methylene bisacrylamide followed by UV-initiated crosslinking to yield a fully interpenetrating polymer network of the polyether urethane and poly(acrylic acid). The IPN was then washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
In another example, a polyether urethane (Elasthane™ 75D) was injection molded, dip-casted (solution casted) on one side in a polyether urethane solution (Elasthane™ 55D in 25% DMAC) and dried in a convection oven to remove the DMAC solvent. The dried material was swollen in 70% acrylic acid with the 70% acrylic acid with 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% w/w methylene bisacrylamide followed by UV-initiated crosslinking to yield a fully interpenetrating polymer network of the polyether urethane and poly(acrylic acid). The IPN was then washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
In another example, a polycarbonate urethane (Bionate 75D) was injection molded, dip-casted (solution casted) on one side in a polyether urethane solution (Elasthane™ 55D in 25% DMAC) and dried in a convection oven to remove the DMAC solvent. The dried material was swollen in 70% acrylic acid with 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% w/w methylene bisacrylamide followed by UV-initiated crosslinking to yield a fully interpenetrating polymer network of the polyether urethane and poly(acrylic acid). The IPN was then washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
In another example, a polyether urethane (Elasthane™ 75D) was injection molded and then dip-casted (solution casted) in a methacryloxy-functionalized polyether urethane solution (Elasthane™ 55D in 25% DMAC) along with the aforementioned photoinitiator and then was exposed to UV light to crosslink the methacryloxy-functionalized polyether urethane. The material was then dried in a convection oven to remove the DMAC solvent. The dried material was then swollen in 70% acrylic acid with the 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% w/w methylene bisacrylamide followed by UV-initiated crosslinking to yield a fully interpenetrating polymer network of the polyether urethane and poly(acrylic acid). The IPN was then washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
In another example, a polycarbonate urethane (Bionate 75D) was injection molded and then dip-casted (solution casted) in a methacryloxy-functionalized polyether urethane solution (Elasthane™ 55D in 25% DMAC) and then was exposed to UV light to crosslink the methacryloxy-functionalized polyether urethane. The material was then dried in a convection oven to remove the DMAC solvent. The dried material was then swollen in 70% acrylic acid with the 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% v/v triethylene glycol dimethacrylate followed by UV-initiated crosslinking to yield a fully interpenetrating polymer network of the polyether urethane and poly(acrylic acid). The IPN was then washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
In another example, a polyether urethane (Elasthane™ 55D) solution casted and then swollen in 35% sulfopropyl methacrylate in acetic acid with 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% w/w methylene bisacrylamide followed by UV-initiated crosslinking to yield a fully interpenetrating polymer network of the polyether urethane and poly(acrylic acid). The semi-IPN was then washed with water to remove the acetic acid, and then in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
In another example, a polyether urethane (Elasthane™ 55D) solution casted and then swollen in 35% sulfopropyl methacrylate and 35% acrylic acid in water with the 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% w/w methylene bisacrylamide followed by UV-initiated crosslinking to yield a fully interpenetrating polymer network of the polyether urethane and poly(acrylic acid). The semi-IPN was then washed in an aqueous salt solution to neutralize the poly(acrylic acid)/poly(sulfopropyl methacrylate) copolymer, achieve equilibrium swelling, and remove any unreacted monomers.
In another example, a rectangular sample of PMMA (plexiglass) was swollen briefly in 100% acrylic acid in water with the 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% w/w methylene bisacrylamide followed by UV-initiated crosslinking to yield a fully interpenetrating polymer network of the PMMA and poly(acrylic acid). The IPN was then washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
In another example, a rectangular specimen of polydimethyl sulfoxide (PDMS, Sylgard® 184) was prepared according to the manufacturer's specifications and then was swollen briefly in a 35% acrylic acid solution in tetrahydrofuran along with 0.1% v/v 2-hydroxy-2-methyl propiophenone and 0.1% v/v triethylene glycol dimethacrylate, followed by UV-initiated crosslinking to yield a fully interpenetrating polymer network of the PDMS and poly(acrylic acid). The IPN was washed in an aqueous salt solution to neutralize the poly(acrylic acid), achieve equilibrium swelling, and remove any unreacted monomers.
The contact angle between the charged hydrogel IPN made by this invention and water was determined. Briefly, a sheet of Elasthane™ 55D (polyetherurethane) was soaked in acrylic acid with initiator and cross-linker, and cured to form a semi- IPN (PEU/PAA semi IPN). After curing, the charged PEU/PAA semi IPN was hydrated in phosphate buffered saline. The material was removed from the solution and its surface briefly dabbed to remove any residual liquid. A drop of water was placed on the surface of the material, and the contact angle read using a Goniometer. The results showed a contact angle of approximately 8° . For comparison, readings taken on starting materials of solution-casted polyurethanes and injection-molded polyurethane had contact angles of approximately 72° and 69° , respectively. This result demonstrates that the incorporation of a poly(acrylic acid) network into polyurethane according to the current invention dramatically increases surface hydrophilicity.
The differences in the structures of the charged hydrogel IPN and polyurethane are shown by Transmission Electron Microscopy (TEM). TEM creates a highly magnified image of a material. TEM was performed on samples of polyetherurethane/poly(acrylic) acid semi IPN (PEU/PAA semi IPN) of the current invention and of unmodified polyetherurethane. Briefly, a sheet of Elasthane™ 55D (polyetherurethane) was soaked in acrylic acid with initiator and cross-linker, and cured. It was stained with osmium tetroxide per standard procedures to perform TEM analysis.
The coefficient of friction μ of a PEU/PAA semi-IPN of this invention against itself was measured real-time during a wear test using a built-in torque cell, and was found to range between 0.015 to 0.06, and as shown in
The coefficient of friction is a number that indicates the force resisting lateral motion of an object. It is expressed as a unitless ratio of the frictional force to the normal force. The dynamic coefficient of friction for the polyether urethane/polyacrylic acid (PEU/PAA) semi-IPN on was tested on metal, and the dynamic coefficient of friction is shown as a function of time. Briefly, a piece of Elasthane™ 55D (polyetherurethane) was soaked in acrylic acid with an initiator and cross-linker, and cured to form a water swellable semi-IPN of the present invention. Plugs 8.8 mm in diameter and 1 mm thick were cut, swollen in PBS, and then rotated at a frequency of 1 Hz against a 3/16″ stainless steel disc at a contact stress of 2.0 MPa while being submerged in PBS. Using a custom-made wear tester made according to ASTM F732 standards equipped with both a force load cell and a torque load cell, the dynamic coefficient of friction was measured real-time during the wear test experiment. The dynamic coefficient of friction of the material varied between 0.005 and 0.015 over a period of 36 hours.
Wear experiments of the PEU/PAA semi-IPN of this invention were conducted according to ASTM F732 using a pin-on-disc configuration. Results are shown in
In the test of the PEU/PAA semi IPN of this invention, the pins were 8.8 mm in diameter, 2.5 mm in thickness. The disc was 88 mm in diameter and 2.5 mm in thickness. The pins were rotated over the disc at a radius of 24 mm and at a rate of 1.33 Hz under a pneumatically applied cyclic load. A pressure regulator was used to adjust the air pressure so that the desired force was applied. The load was measured using a load cell (Sensotec Honeywell, CA) directly under the disc. The disc and the pins were mechanically isolated so that the torque caused by the friction generated between them can be measured by a torque cell (Transducer Techniques, CA) connected to a computer equipped with a data acquisition card (National Instruments, Tex.). The pin and discs were contained in a chamber filled with PBS. The temperature was controlled and kept constant at 37° C. using a thermocouple-resistor-fan system. Using the equation μ=T/r*F, where T is the measured torque, r is the radius of rotation (=24 mm) and F being the total force applied on the pins, the coefficient of friction was constantly monitored. The coefficient of friction was found to be 0.016 and independent of the contact pressure (range tested 0.1-3.5MPa) and slightly increased to 0.021 under heavy static contact load, but returned to the original value after fluid recovery. The wear was measured using the gravimetric method every million cycles: the disc and the pins were weighed separately after vacuum drying for 3 days. The wear test solution (PBS) was collected and visually examined; no signs of visible wear particles were noted at all steps of the tests. The wear test PBS solution was vacuum filtered using a 2.5 μm pore filter to capture any wear particles, flushed with deionized water to remove remaining PBS salts and then dried overnight under vacuum and desiccant. As a control, a similar test was performed using CoCr pins (Fort Wayne Metals, IN) on UHMWPE (Orthoplastics, UK). Three polished (Ra<1.6 μm) CoCr flat pins of OD=7 mm were tested in the same instrument against a polished UHMWPE disc of 2.5 mm thickness and OD=88 mm (rotation radius=24 mm), rotating at 1.2 Hz under 3.4 MPa static contact load and at 37° C. isolated environment.
Observation of the disc formed from the PEU/PAA semi-IPN of this invention after the test (
Weighing of the wear test solution filtrate using a scale with a 0.01 mg resolution (Mettler Toledo, OH) showed that the volumetric wear rate of the PEU/PAA semi-IPN was approximately 0.6 mg/106 cycles or 0.63 mm3/106 cycles or 0.63 mm3/150×103 m. This value, however is close to the resolution of the methods. A schematic of the wear test solution from the wear test of the inventive joint interface material comprised of PEU/PAA semi-IPN is shown in
Although attention was paid to eliminate external factors such as dust, moisture and static in order to increase the accuracy of the results, the wear values are well near the statistical and practical detection limits of the methods available. These results are consistent with the hypothesis that since the PEU/PAA semi IPN according to the present invention—like natural cartilage—is comprised of mostly water, and the surface is persistently lubricated with a film of water, there is little, if any, contact between solid matrices.
Wear particle measurements were also taken for the CoCr-on-UHMWPE experiments, which not only created a visible wear track (
The swelling of polyetherurethane by acrylic acid in water and acetic acid was tested. Swelling solutions were prepared containing 10, 30, 50, and 70% acrylic acid monomer in deionized water (
Swelling solutions were prepared containing 10, 30, 50, and 70% acrylic acid monomer in deionized water and in acetic acid. Small pieces of Elasthane™ 55D (polyetherurethane) were obtained and weighed. Samples were placed in each of the water/acrylic acid or acetic acid/acrylic acid solutions along with cross-linker and initiator. The samples were cured, swollen in acrylic acid in either water or acetic acid, removed from the solution, dried, and then weighed again. Incorporation of acrylic acid into the Elasthane™ 55D to form a semi-IPN was observed using either water or acetic acid as solvent. More incorporation of acrylic acid was observed when a higher concentration of acrylic acid was present in the swelling solution.
Semi IPNs were prepared essentially as described in
A sample of the PEU/PAA semi IPN was removed and measured in the direction of its thickness, subject to cycles of compressive stress from 0-3 MPa at a frequency of 1 Hz for over 60,000 cycles, measured again in the direction of its thickness, re-equilibrated (relaxed) in PBS to allow for recovery from creep, and measured again in the direction of its thickness.
A static creep test was also performed (data not shown). Creep is the time-dependent deformation of a material under a constant load. The behavior of the PEU/PAA semi IPN tested under static compression was tested following ASTM D2290-01 “Standard Test Methods for Tensile, Compressive, and Flexural Creep and Creep-Rupture of Plastics”. A plug of the PEU/PAA semi IPN with an initial diameter of 9.525 mm and a thickness of 1.115 mm was put under an initial stress 4 MPa in a fluid PBS bath. After applying the stress for approximately 20,000 seconds (to a total strain of 14.29%), the load was released and the material allowed to relax (re-equilibrate) in PBS. The final thickness of the plug was 1.109 mm. The final unrecovered creep after more than 40,000 cycles was 2.7%.
The bone-interface material of
An additional embodiment of the present invention takes advantage of the high mechanical strength of hydrophobic thermoset or thermoplastic polymers high mechanical strength of hydrophobic thermset or thermoplastic polymers and combines those materials with certain non-ionic polymers as a useful way to achieve increased mechanical strength with greater adhesiveness. Because of their mechanical strength, it has been desirable to use hydrophobic thermoset or thermoplastic polymer containing materials in load bearing or structural support components for a variety of purposes. For example, as discussed above, hydrophobic thermoset or thermoplastic polymers such as polyurethane can be formed into medical implants such as those used for joint arthroplasty.
This use, however, is often limited by the ability to securely attach the hydrophobic thermoset or thermoplastic polymer containing materials to a destined location or substrate. For example, a femoral head cap implant for hip replacement must be fixed to a patient's femoral head in the hip joint. To ensure patient safety and proper operation of the implant, the implant must be properly adhered to the surface of the femoral head.
In cases with high stiffness devices such as cobalt chrome, titanium, or hard plastic-ultra-high-molecular-weight polyethylene (UHMWPE), bone cements have been used as bonding/adhesive agents to fix these devices to bone. Such bone cements generally fill the meeting spaces between and on the surfaces of the device and the bone, thereby fixing the device to the bone. However, with more compliant materials that can be made from hydrophobic thermoset or thermoplastic polymers (such as polyurethane), the mechanical strength of the material and the adhesiveness between the bone cement and the implant is of particular importance in that compliant materials may conform their shapes under load.
For example, failure to provide adequate adhesion could result in sliding, dislodgement, loosening, and general movement of the implant from its proper placement. Such movement can cause pain, weaken and render the implant inoperable, and require corrective surgeries.
Various formulations and developments of cements, adhesives, fillers, bonding agents, and mechanical fixation components such as mating pegs, screws, and grooves have been suggested to address this concern. However, these approaches focus on the bonding agents or the mechanical attachment components rather than on the composition and characteristics of the compliant materials containing hydrophobic thermoset or thermoplastic polymers. One embodiment of this invention introduces materials and articles that comprise IPNs or semi-IPNs which exhibit strong adhesion with other materials such as orthopaedic anchoring compounds while also providing high mechanical strength or stiffness. The terms interlocking agent, grouting agent, anchoring compound, adhesive agent, and/or bonding agent refer broadly and interchangeably to materials that are capable of binding, fusing, adhering, filling, cementing, affixing, or otherwise attaching one material, article, object, component etc. to another.
As discussed previously, hydrophobic thermoset or thermoplastic polymers can be infused with various monomers that are polymerized to form an IPN or a semi-IPN. In some instances, the IPN or semi-IPN can extend throughout the bulk of the material or throughout only a portion of the material, e.g. a particular region or in a gradient. Depending on the selection of the monomer, the resulting IPN or semi-IPN can exhibit a variety of properties (e.g. stiffness, lubriciousness, strength, conductivity, etc.) and variability of range within each property.
The property or properties imparted depend on several factors including, but not limited to, the monomer(s) selected, the degree of monomer penetration into the hydrophobic thermoset or thermoplastic polymers prior to monomer polymerization, the grade of the hydrophobic thermoset or thermoplastic polymers, whether the hydrophobic thermoset or thermoplastic polymers are phase-separated, whether the monomer penetration is in a single region or multiple portions of the hydrophobic thermoset or thermoplastic polymers etc.
As discussed above,
The new properties provided by this IPN depend on the properties of the polymerized monomers that were introduced and on any optional post-polymerization processing. Examples of such new properties include lubriciousness, conductivity, hardness, absorbency, permeability, photoreactivity and thermal reactivity. In some embodiments, an adhesiveness property can be achieved by introducing a non-ionic polymer into hydrophobic thermoset or thermoplastic polymers to form an IPN or semi-IPN. In these embodiments, the non-ionic polymer can be selected based on the presence of the non-ionic polymer in the material to be adhered to the IPN or semi-IPN.
By way of example, in some embodiments, a material containing polyurethane may be destined for use as a joint implant that will be attached to a bone's surface with bone cement. The majority of load bearing orthopaedic bone cements comprise non-ionic polymers derived from ethylenically unsaturated monomers without ionizable functional groups, like methyl methacrylate (MMA) and styrene, or combinations thereof. Many commercially available bone cements contain a polymethylmethacrylate (PMMA) polymer or copolymer.
Typically, for PMMA bone cements, MMA monomers are initially present in a liquid state prior to bonding. To activate the bone cement, the MMA is cured (polymerized) in situ to act like a grout or filler that interdigitates with the bone trabecular space and the features of the device to be implanted. This forms an interlock between the device, PMMA bone cement, and the bone that secures device fixation.
For materials containing hydrophobic thermoset or thermoplastic polymers, bonding through interdigitation can be complemented by adhesion between an IPN or semi-IPN in the material and the bonding agent. Where a PMMA bone cement is used, PMMA can be employed as the non-ionic polymer component of a IPN or semi-IPN with hydrophobic thermoset or thermoplastic polymers. MMA monomers can be introduced by infusion/diffusion into the hydrophobic thermoset or thermoplastic polymers and polymerized to form an IPN or semi-IPN within the starting material. Once formed, the PMMA in the IPN or semi-IPN is fused and compositionally continuous with the PMMA in the bone cement.
Without being bound to any theory, it is believed that the non-ionic polymer present in the bonding agent (e.g. as a constituent/ingredient) fuses to the non-ionic polymer phase of the IPN or semi-IPN, thereby providing actual adhesion between the bonding agent and the material containing the IPN. It is further believed that adding one or more layer(s) of the bonding agent to the IPN will result in strong adhesion between the IPN containing material and the bonding agent, which serves to facilitate a strong adhesion between the IPN containing material and a destination location (e.g. bone surface).
Stiffness, adhesion, and shear strength tests were conducted on the resulting PMMA-polyurethane-IPN 802. Test results show that the PMMA-polyurethane-IPN exhibited increased stiffness, greater adhesiveness, and greater shear strength compared to the original polyurethane plate without the IPN.
With regard to stiffness, compressive tests in a universal testing machine revealed that an Elasthane™ 55D plug of OD=10 mm and 4 mm thickness had a stiffness modulus of 80 MPa whereas after the formation of a PMMA-polyurethane-IPN (at 70%-30% proportions) the stiffness modulus increase to approximately 1.5 GPa.
Although a commercially available polyurethane product, Elasthane, Bionate, Pursil, or Sylgard was used in some examples as a hydrophobic thermoset/thermoplastic polymer, it is understood in the art that any suitable hydrophobic thermoset/thermoplastic polymer may be used and there is no limitation as to the particular commercial products/tradenames described herein.
Although the examples above illustrate the use of the MMA monomer to form a PMMA-polyurethane-IPN, it can appreciated that any number of suitable monomers can be used to form an IPN or semi-IPN which imparts properties such as stiffness, strength, or adhesiveness to a thermoset / thermoplastic polymer starting material. This can be understood more generally as an IPN or a semi-IPN formed in a material containing a hydrophobic thermoset or thermoplastic polymer T by introducing a monomer P′ into thermoset or thermoplastic polymer T, which is then polymerized from monomer P′ to penetrating polymer P.
In other embodiments, an exemplary list of monomer P′ suitable for this process include any number or combinations of ethylenically unsaturated monomers that are not ionizable, i.e. do not have chemical groups that can bear positive or negative charge such as (but not limited to) methyl acrylate, methyl methacrylate, hydroxyethyl acrylate/methacrylate, and styrene. In further embodiments, suitable non-ionic polymers P include polymethylmethacrylate, polystyrene, or a PMMA-polystyrene copolymer.
In further embodiments an exemplary list of hydrophobic polymers modifiable by the process of this invention includes the following: Acrylonitrile butadiene styrene (ABS), Polymethylmethacrylate (PMMA), Acrylic, Celluloid, Cellulose acetate, Ethylene-Vinyl Acetate (EVA), Ethylene vinyl alcohol (EVAL), Kydex, a trademarked acrylic/PVC alloy, Liquid Crystal Polymer (LCP), Polyacetal (POM or Acetal), Polyacrylates (Acrylic), Polyacrylonitrile (PAN or Acrylonitrile), Polyamide (PA or Nylon), Polyamide-imide (PAI), Polyaryletherketone (PAEK or Ketone), Polyhydroxyalkanoates (PHAs), Polyketone (PK), Polyester, Polyetheretherketone (PEEK), Polyetherimide (PEI), Polyethersulfone (PES)- see Polysulfone, Polyethylenechlorinates (PEC), Polyimide (PI), Polymethylpentene (PMP), Polyphenylene oxide (PPO), Polyphenylene sulfide (PPS), Polyphthalamide (PPA), Polystyrene (PS), Polysulfone (PSU), Polyvinyl acetate (PVA), Polyvinyl chloride (PVC), Polyvinylidene chloride (PVDC), Spectralon, Styrene-acrylonitrile (SAN), Polydimethylsiloxane (PDMS), and Polyurethanes (PU).
As discussed, to impart adhesiveness, any number or combination of hydrophobic thermoset or thermoplastic polymers and non-ionic polymers can be employed to form a suitable IPN or semi-IPN. In some instances, the non-ionic polymer P for forming the IPN or semi-IPN is selected based on its presence as an ingredient or constituent in a material to be adhered to by the IPN or semi-IPN (i.e. the material also contains some amount of non-ionic polymer P.) In other alternative embodiments, the non-ionic polymer P is selected based on its affinity to the material where the non-ionic polymer P may not be a constituent of the material. For example, non-ionic polymer P may exhibit affinity to other constituents present in a bonding agent. The formulation of a commercially available bone cement is provided below as an example of non-ionic polymer components present in an anchoring material that can be used to form an IPN:
Additionally, in some embodiments, the adhesive force between an anchoring compound or bonding material and a hydrophobic thermoset or thermoplastic-non-ionic polymer-IPN device can be increased by adding roughness (micron-to-millimeter level) to the device or/and by adding anchoring features such as grooves, pegs, protrusions, recessions, etc. The roughness or the features can added to the device by construction (during for example injection molding) or at a later stage by addition (gluing, solution casting, etc.)
Moreover, the IPN can incorporate either chemically or physically within its bulk or its surface certain additives such as antioxidants (e.g., Vitamin C, Vitamin E, Irganox®, or santowhite powder) and/or anti-microbial agents (e.g., antibiotics). These can be chemically linked to the material by, for example, esterification of the anti-oxidant with any vinyl-group containing monomer such as methacrylate, acrylate, acrylamide, vinyl, or allyl ether.
Another aspect of this invention provides a process for preparing the IPN or semi-IPNs as described. As discussed above, a process of preparing an IPN or a semi-IPN includes placing a monomer solution in contact with a hydrophobic thermoset or thermoplastic polymer, diffusing the monomer solution into the thermoset or thermoplastic polymer; and polymerizing the monomers to form a polymer within the thermoset or thermoplastic polymer, which results in an IPN or semi-IPN. As also described above, selection of the monomer(s) or thermoset or thermoplastic polymer and/or the conditions of each part of the process can affect the properties of the resulting IPN/semi-IPN.
To form an adhesive IPN/semi-IPN with non-ionic polymer P, a non-ionizable monomer P′ solution can be placed in contact with a solid form of a hydrophobic thermoset or thermoplastic polymer T. The non-ionizable monomer P′ solution is allowed to infiltrate and penetrate through the thermoset or thermoplastic polymer T. Once a suitable degree of penetration occurs, the monomer P′ is polymerized in the thermoset or thermoplastic polymer T to form an IPN/semi-IPN that has an adhesiveness property when the non-ionic polymer P phase in the IPN/semi-IPN is brought into contact with a bonding agent containing the same non-ionic polymer P.
Polymerization can be accomplished by dissolving 1% (w/w) 2-hydroxy-2-methylpropiophenone photoinitiator in an MMA solution, swelling the polyurethane with the MMA/photoinitiator solution, and shining UV light at 2 mW/cm2 for 10 minutes onto the swollen polyurethane. However, any number of photoinitiators and concentrations thereof can also be used depending on their solubility with the precursor solutions/materials.
Penetration of the monomer P′ into the starting material can be carried out by submersing and swelling the entire material or piece with a monomer solution for a predetermined amount of time. Alternatively, the swelling can be done by partially exposing the material to a monomer solution, thereby reaching a partial or one side treatment. Depending on the swelling time and/or factors, a desired degree of treatment can be achieved on regions of the material. For example, in some embodiments, the monomer P′ infusion occurs by submerging the entire thermoset or thermoplastic polymer T solid form in the monomer P′ solution. In further embodiments, a section or region of the thermoset or thermoplastic polymer T solid form is exposed to the monomer P′ solution without fully immersing the solid form in the solution. In further embodiments, the entirety of the thermoset or thermoplastic polymer T may ultimately be placed in contact with the monomer P′ solution; however, the exposure process may include iterative contacts to various regions of the solid form to ultimately expose the entire solid form to the monomer P′ solution.
As shown in
As can be appreciated in the art, the terms “entire” or “entirety” is not limited to all available surface area or volume of the solid form. Rather, the terms broadly refer to the points, area, volume, etc. that may be available for contact or exposure by the solution. For example, in some embodiments, the available exposure space on a solid form capable of forming an IPN/semi-IPN may be less than the full surface area or volume provided by the dimensions of the solid form.
In further embodiments, where the IPN/semi-IPN need only be present in a portion, side, quadrant, or region of the solid form, one or more section(s) of the thermoset or thermoplastic polymer can be selectively exposed to the monomer P′ solution. For example, in the case of a joint implant made with a.thermoset or thermoplastic polymer, the bone interfacing surface may be modified to include an IPN/semi-IPN to strengthen the implant and facilitate adhesion of the device to a bone cement. In such embodiments, the monomer P′ solution is placed in contact with the thermoset or thermoplastic polymers in the bone interfacing surface of the device. The monomer P′ solution is allowed to diffuse into the implant to the extent sufficient to impart adhesiveness and higher mechanical strength in the target location of the implant.
Affecting the amount or degree of diffusion into the implant can be accomplished by controlling the conditions of the diffusion. For example, conditions that can affect the degree of IPN penetration include modifying exposure time to the monomer P′ solution, grade of the solid form, concentration of the monomer P′ solution, region(s) of the solid form exposed, etc. By modifying any number or combination of these conditions (or others) the regions and degrees of adhesiveness, stiffness, shear strength, etc. can be adjusted to a suitable amount.
In additional embodiments, a solvent can be used to deliver monomers that otherwise would not mix easily (or solubilize) with the polymer or to one (or more phases) of the polymer. Solvents that can be used include, but are not limited to, di- or trichloromethane and dimethyl sulfoxide (DMSO). Depending on the solubilities in the phases of the polymer, solvents with varying degrees of swelling the polymer can be determined. Solubilities of the solvents and component material to be swollen can be obtained from polymer textbooks such as The Polymer Handbook or measured experimentally.
In another aspect of the invention, a concentration gradient can form within the starting homopolymer or thermoset/thermoplastic polymer. As shown in
In some embodiments, a concentration gradient can be created by employing an IPN in a homopolymer where the concentration of the IPN changes from one region of the starting material to another. For example, a monomer solution that is allowed to diffuse into only one side of a polyurethane solid form will form an IPN through a thickness on that side of the solid form. The resulting material can contain a side with pure polyurethane and a side with IPN. Within the IPN side, the concentration of the penetrating polymer may not be uniform and, in some instances, will show a higher concentration of penetrating polymer at the site of direct exposure (surface that was in direct contact with the monomer solution) and diminishing concentration of the penetrating polymer through a thickness of the solid form from the site of direct exposure. A transition area may exist between the IPN and the pure polyurethane regions where the concentration of the penetrating polymer diminishes until effectively the IPN region merges with a non-IPN region of pure polyurethane.
In some variations, a concentration gradient can form by adjusting the exposure time or area of the thermoset/thermoplastic polymer in a monomer solution. Similarly, a concentration gradient can also result by limiting the exposure time of the solid form to the monomer solution. Depending on these and other factors, a gradient of material composition across a section (e.g. thickness) of the polyurethane solid form can be achieved.
By way of example, a concentration gradient can be created in a solid form of polyurethane by exposing one side of the solid form to a MMA solution. The MMA monomers penetrate the solid form through the contact side but can be limited in the degree of diffusion by factors such as the area available for penetration, exposure time, and the structure of the solid form (e.g. phases present in the thermoset/thermoplastic polymer). Once the MMA monomers are allowed to diffuse through one side of the solid form, the monomers are polymerized to form a PMMA IPN/semi-IPN within the solid form. In this example, the resulting material can exhibit a concentration or composition gradient with the IPN/semi-IPN on one side, the thermoset/thermoplastic polymer on another side, and a transition region with decreasing PMMA content from one side to the other. In some embodiments, the concentration gradient allows regions of the starting structure to exhibit properties such as greater stiffness, adhesiveness, or strength while at the same time preserving sections having the original material.
The use of concentration gradients within thermoset/thermoplastic polymer materials is especially advantageous in the creation of osteochondral grafts for orthopaedic joint replacement materials. For instance, in the case of a joint arthoplasty, the bone interfacing side of a polyurethane implant is exposed to a MMA monomer such that it forms a PMMA-polyurethane IPN through a thickness of the implant. While one side of the implant remains pure thermoplastic, the bone interfacing surface exhibits greater adhesiveness while the IPN also provides increased mechanical strength through the thickness of the implant where the IPN exists. A PMMA bone cement can be applied to the IPN (bone interfacing) surface to facilitate bonding of the implant to a bone surface.
In further embodiments, the starting material for the concentration gradient is a lubricious hydrophobic thermoset/thermoplastic material. Such materials may be one of those previously discussed such as a thermoset or thermoplastic polymer with a lubricious IPN/semi-IPN. For example, an orthopaedic device 900 that is designed to replace femoral head cartilage is shown in
The polyurethane of the example above may be formed by any process and may contain any additional materials, including but not limited to those described in U.S. patent application Ser. No. 12/148,534 filed Apr. 17, 2008 and entitled “Hydrogel Arthroplasty Device”, U.S. patent application Ser. No. 12/499,041, filed Jul. 7, 2009, and entitled “Hydrophilic Interpenetrating Polymer Networks Derived from Hydrophobic Polymers”, U.S. patent application Ser. No. 12/536,233 filed Aug. 5, 2009 and entitled “Polyurethane-Grafted Hydrogels”.
As described above, the forming or shaping of the IPN and semi-IPN articles according to embodiments of this invention can be done prior to or after creating the IPN/semi-IPN in the material. For example, a solid form of polyurethane can be pre-formed into a joint implant having a bone interfacing surface and a joint interfacing surface. The implant is then exposed to a monomer solution, which is polymerized to an IPN/semi-IPN in the implant.
Another aspect of the invention takes advantage of the high mechanical strength of thermoset or thermoplastic polymers and the ability to modify these materials to impart more than one desired property. For example, a thermoset or thermoplastic polymer can be made lubricious, conductive, and adhesive through the use of combinations of monomers and IPNs.
More than one property can be imparted to a hydrophobic thermoset/thermoplastic polymer by introducing a first monomer solution into the thermoset/thermoplastic polymer and polymerizing to form a first IPN/semi-IPN in the thermoplastic polymer. The process can be further repeated to introduce additional IPNs/semi-IPNs to the starting polymer.
This process is particularly useful where different sections of the starting material require different properties or sets of properties from other sections. For example, a polyurethane femoral head cap implant has a bone interfacing surface that will engage and affix to a femur surface and a joint interfacing surface that will engage the hip socket. To securely affix the implant to the bone, implant's bone interfacing surface can be infused with a monomer (e.g. MMA) solution capable of imparting adhesiveness, stiffness, or strength. With a MMA solution, the MMA monomers penetrate the bone interfacing surface of the implant and polymerize to form a PMMA-polyurethane IPN/semi-IPN in the bone interfacing surface. On the joint interfacing surface, a hydrophilic polymer can impart a lubricious surface that mimics natural cartilage. To do so, the joint interfacing surface is infused with an ionic monomer solution that polymerizes to form a hydrophilic IPN/semi-IPN in the joint surface.
In some embodiments, the multiple IPNs/semi-IPNs share the same starting thermoset/thermoplastic polymer with different penetrating polymers. This can be understood as a material containing an IPN/semi-IPN with a penetrating polymer P and a thermoset or thermoplastic polymer T and another IPN/semi-IPN with the same thermoset/thermoplastic polymer T and a penetrating polymer S. Multiple IPNs/semi-IPNs can exist in the same, overlapping, or distinct regions of the starting material. In the implant example above, the adhesive IPN on the bone interfacing surface and the lubricious IPN on the joint interfacing are disposed on different sides of the implant where the two IPNs do not overlap. However, multiple IPNs may coexist or overlap in sections of the material. Similarly, in some embodiments, multiple IPNs may overlap in certain portions of the material but not in others. Additionally, starting material or non-IPN region may be disposed adjacent to an IPN section such that the starting material region is next to one or more IPN sections. For example, a starting material region may be “sandwiched” between two IPN regions.
Moreover, the multiple IPNs/semi-IPNs do not necessarily provide different properties to the material. Some materials contemplated include more than one lubricious portion while other materials may have multiple adhesive sections. In embodiments where more than one bonding agent is used on a material, it is understood that the same IPN may not have the same degree of affinity to the different bonding agents (e.g. a PMMA-IPN may not adhere as well to bone cement with a high polystyrene content). In such cases, different penetrating polymers may be used to form different adhesive IPNs where each IPN is configured to optimize bonding with a target substance or material.
Alternatively, the multiple IPNs/semi-IPNs may employ the same penetrating polymer. For example, a polyurethane solid form may contain a PMMA-polyurethane-IPN on two different surfaces. In some instances, one IPN may be formed first and a second IPN with the same penetrating polymer formed at a later time.
Furthermore, as can be appreciated in the art, any combination of hydrophobic, non-ionic, hydrophilic, and ionic polymers can be used with a thermoset/thermoplastic starting polymer to create one or more IPNs/semi-IPNs in the starting polymer. For example, a material may contain two hydrophobic or two hydrophilic IPNs or combinations, variations, or permutations thereof.
As discussed, in some embodiments, the process of preparing multiple IPNs/semi-IPNs in a thermoset or thermoplastic polymer solid form includes the steps of placing at least one region of the solid form in contact with a monomer solution, diffusing the monomer solution into the thermoset / thermoplastic polymer, polymerizing the monomer into a penetrating polymer, and repeating these steps with additional monomer solutions. In other embodiments, the thermoset or thermoplastic polymer solid form is exposed and swollen with each of the monomer solutions before polymerization of the monomers into their respective penetrating polymers. Depending on the desired product, the process can be modified to adjust the placement of the IPNs/semi-IPNs. For example, each of the IPNs/semi-IPNs can overlap or exist in separate regions of the hydrophobic thermoset or thermoplastic polymers.
In additional embodiments, more than one concentration gradient can form in a thermoset/thermoplastic polymer with multiple IPNs/semi-IPNs. In some instances, a material having two IPNs (or more) may have two or more concentration gradients where each gradient provides regions of varying degrees of penetrating polymer concentration and varying degrees of imparted properties. As with the gradients discussed previously, the concentration gradient can be created by adjusting conditions such as the thermoset/thermoplastic polymer's exposure area and time to a monomer solution. By adjusting conditions for one or more of the monomer solutions employed, multiple concentration gradients can exist in the starting material.
For example,
In some embodiments, this process forms two IPNs with two concentration gradients, one on the lubricious side with surface 912 and one on the anchoring side with surface 914. The concentration gradient on the lubricious side may exhibit diminishing concentration of the penetrating polymer through a thickness of the implant, whereby the properties of the IPN may also decrease through a thickness of the implant in relation to the concentration of the penetrating polymer in the IPN. For example, an IPN area of higher concentration of the penetrating polymer may have a higher degree of lubriciousness than an area of lower concentration. Similarly, on the anchoring side with surface 914, the concentration of the penetrating non-ionic polymer may also diminish from one region to another through the IPN and afford a relative reduction in adhesiveness through the same area.
Because there are numerous ways of creating and placing multiple IPNs (and concentration gradients) on a starting material, behavior of a concentration gradient is not limited to diminishing concentration of a penetrating polymer through a thickness of a starting material. Gradients can be formed across a surface rather than a thickness of a material. Moreover, multiple IPNs may overlap partially or fully at regions in the starting material, or alternatively, multiple IPNs may be placed in distinct and separate regions. For example,
In the above example, it is understood that the multiple IPNs/semi-IPNs share the same starting thermoset/thermoplastic polymer with different penetrating polymers. This can be understood as an implant containing an IPN/semi-IPN with a penetrating polymer P and a thermoset or thermoplastic polymer T and another IPN/semi-IPN with the same thermoset or thermoplastic polymer T and a penetrating polymer S. In additional embodiments, the hydrophobic thermoset/thermoplastic material can include more than a double gradient, e.g. triple or more gradients imparted by multiple IPNs/semi-IPNs.
Moreover, in some embodiments, gradients such as those described in
In a further example,
The components and devices described can be formed into any number of designs for use such as grafts, patches, plugs, and total surface replacement. For example,
In further embodiments, the graft, patch, plug, etc. may be implants or devices designed to partially cover or replace cartilage surface.
Additionally,
In some embodiments, an osteochondral graft such as a plug with one or more IPNs/semi-IPNs may also include a porous bone interfacing material. The porous bone interfacing layer can be added to a bone interfacing portion of a device to facilitate bone ingrowth and integration. In some embodiments, a lubricious, cartilage-like synthetic region and surface may be disposed on one side of the graft and an adhesive bone interfacing region and surface may be anchored to another side. The adhesive bone interfacing region may further include a porous bone or a synthetic, porous bone-like structure. In one embodiment, the lubricious region consists of an interpenetrating polymer network that is composed of two polymers. The first polymer may be a hydrophobic thermoplastic with high mechanical strength, including but not limited to polyether urethane, polycarbonate urethane, silicone polyether urethane, and silicone polycarbonate urethanes, or these materials with incorporated urea linkages, or these materials with incorporated urea linkages (e.g. polyurethane urea). The second polymer may be a hydrophilic polymer derived from ionizable, vinyl monomers, including but not limited to acrylic acid and/or sulfopropyl methacrylate.
The adhesive region may consist of another interpenetrating polymer network that is composed of the same hydrophobic thermoplastic polymer of the lubricious region and a non-ionic polymer such as PMMA. A porous bone interface material, such as the one shown in
In further examples, the devices and components of the embodiments described may include a porous bone-interfacing material or layer such as the ones shown in
Furthermore, although the starting polymers have been described as hydrophobic thermoset or thermoplastic polymers, other suitable starting polymers known in the art such as polyethylene glycol or polyvinyl alcohol may be used as a starting material.
Another aspect of the present invention relates to a group of new polyurethane structures (polyurethane-polyacrylic acids; PU-PAA) and their IPNs which provide superior hydrolytical resistance, oxidative stability and creep resistance through covalently bonded crosslinks. In further embodiments, medical devices such as prostheses for a body, including joint prostheses are made from these materials.
In some embodiments, the new group of polyurethane structures may form polyurethane precursor material with structural integrity similar to Elasthane™ grade polyurethanes, such as resistance to hydrolysis and/or oxidation and/or creep; allow for cross linking with a subsequently added second network that is formed by polymerizing acrylic acid that has previously swollen the polyurethane; and/or allow for subsequent covalent bond formation between antioxidant(s) and polyurethane soft segment (s) after the acrylic acid polymerization.
Although a commercially available polyurethane product, Elasthane, Bionate, Pursil, or Sylgard, was used in some examples as a suitable polyurethane hydrophobic thermoset/thermoplastic polymer, it is understood in the art that any suitable polyurethane containing material may be used and there is no limitation as to the particular commercial products/tradenames described herein.
In some embodiments, example raw materials for the new group of polyurethane structures contemplated are hydroxy-terminated polybutadiene (HTPB) (
Moreover, alternatively, mixtures of HTPB and PTMO or PEG can be used with a concentration that varies from 1-99%. PTMO: polytetramethyleneoxide, PEG: polyethylene glycol.
In some variations, the polymers are prepared according to the following reactions:
MDI+HTPB-→OCN-MDI-HTPB-MDI-NCO to form a prepolymer in bulk.
Any solvent or mixture of solvents may be used to form the prepolymer (e.g. dimethylacetamide (DMAC), dimethylformamide (DMF), dimethylsulfoxide (DMSO), or toluene). The prepolymer is then chain-extended with diols such as butanediol (BD). Any diol or a mixture of diols can be used. The relative ratio of HTPB and PTMO or other soft segment (diol) and/or the molecular weight of the HTPB can be adjusted in order to provide final PUs with desired mechanical properties.
In some embodiments, the resultant PU is soaked with a mixture of aqueous acrylic acid, (photo) initiator and cross-linker and polymerized using any method (e.g. ultraviolet (UV) light, thermal energy, atomic transfer radical polymerization (ATRP), reversible addition-fragmentation chain transfer (RAFT), emulsion polymerization) to form a hybrid of semi-IPN and IPN. PAA (
Any initiator and any cross-linker soluble in the acrylic acid solution may be used. The initiator maybe any, e.g. a photo or thermal initiator (2-hydroxy-2-methylpropiophenone, AIBN, 4,4′-azobis(4-cyanovaleric acid),V-501 by Wako, or V-44(Wako). The cross-linker may be any e.g. bis-acylamide, bis-acrylate, bis-methyacrylate, PEG-diacrylate, or divinylether. The IPN is further modified with an antioxidant such as a hindered-phenol acrylate as shown in
The antioxidant can be covalently bonded to the PU-PAA described in this disclosure through a [2+2] cycloaddition with the -C=C- bonds on the HTPB. A covalently bonded antioxidant will not leach out throughout life time of a medical device made out of the PU-PAA IPN using UV irradiation. The final structure of the end material is shown in
In some embodiments, the resultant material has some or all of the following superior properties: excellent hydrolytical stability; excellent oxidative stability; superior hard segment integrity, reducing the creep and increasing device dimensional stability; extremely low cell adhesion; extremely low protein absorption; better biocompatibility; and no PAA leaching during the lifetime of the device.
As for additional details pertinent to the present invention, materials and manufacturing techniques may be employed as within the level of those with skill in the relevant art. The same may hold true with respect to method-based aspects of the invention in terms of additional acts commonly or logically employed. Also, it is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein. Likewise, reference to a singular item, includes the possibility that there are plural of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “and,” “said,” and “the” include plural referents unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. Unless defined otherwise herein, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The breadth of the present invention is not to be limited by the subject specification, but rather only by the plain meaning of the claim terms employed.
This application claims the benefit of U.S. Patent Application No. 61/377,844 filed Aug. 27, 2010 and U.S. Patent Application No. 61/383,705 filed Sep. 16, 2010. The disclosures of U.S. Patent Application No. 12/499,041 filed Jul. 7, 2009, U.S. Patent Application No. 61/377,844 filed Aug. 27, 2010 and U.S. Patent Application No. 61/383,705 are incorporated herein by reference.
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/US2011/049364 | 8/26/2011 | WO | 00 | 4/24/2013 |
| Number | Date | Country | |
|---|---|---|---|
| 61377844 | Aug 2010 | US | |
| 61383705 | Sep 2010 | US |
